Ligation	O
of	O
CD11b	B-protein
and	O
CD11c	B-protein
beta	I-protein
(	I-protein
2	I-protein
)	I-protein
integrins	B-protein
by	O
antibodies	B-protein
or	O
soluble	B-protein
CD23	I-protein
induces	O
macrophage	B-protein
inflammatory	I-protein
protein	I-protein
1alpha	I-protein
(	O
MIP-1alpha	B-protein
)	O
and	O
MIP-1beta	B-protein
production	O
in	O
primary	B-cell_type
human	I-cell_type
monocytes	I-cell_type
through	O
a	O
pathway	O
dependent	O
on	O
nuclear	B-protein
factor-kappaB	I-protein
.	O

Chemokines	B-protein
and	O
adhesion	B-protein
molecules	I-protein
such	O
as	O
integrins	B-protein
play	O
a	O
major	O
part	O
in	O
the	O
trafficking	O
,	O
extravasation	O
,	O
and	O
recruitment	O
of	O
leukocytes	B-cell_type
to	O
inflammatory	O
sites	O
.	O

This	O
study	O
investigated	O
the	O
effects	O
of	O
beta	O
(	O
2	O
)	O
integrin	O
engagement	O
on	O
chemokine	O
production	O
by	O
freshly	B-cell_type
isolated	I-cell_type
human	I-cell_type
monocytes	I-cell_type
.	O

We	O
found	O
that	O
ligation	O
of	O
CD11b	B-protein
or	O
CD11c	B-protein
but	O
not	O
CD11a	B-protein
alpha	I-protein
chains	I-protein
of	O
beta	B-protein
(	I-protein
2	I-protein
)	I-protein
integrins	I-protein
by	O
antibodies	B-protein
or	O
soluble	B-protein
CD23	I-protein
(	I-protein
sCD23	I-protein
)	I-protein
fusion	I-protein
proteins	I-protein
rapidly	O
induced	O
transcription	O
and	O
secretion	O
of	O
interleukin	B-protein
8	I-protein
,	O
macrophage	B-protein
inflammatory	I-protein
protein	I-protein
(	I-protein
MIP	I-protein
)	I-protein
1alpha	I-protein
,	O
and	O
MIP-1beta	B-protein
.	O

Because	O
the	O
promoters	B-DNA
of	O
these	O
chemokine	B-DNA
genes	I-DNA
contain	O
kappaB	B-DNA
binding	I-DNA
sites	I-DNA
,	O
we	O
assessed	O
the	O
possible	O
role	O
of	O
nuclear	B-protein
factor-kappaB	I-protein
(	O
NF-kappaB	B-protein
)	O
in	O
controlling	O
induction	O
of	O
the	O
genes	O
through	O
beta	O
(	O
2	O
)	O
integrin	O
engagement	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
showed	O
that	O
sCD23	B-protein
or	O
antibodies	B-protein
to	O
CD11b	B-protein
or	O
to	O
CD11c	B-protein
up-regulated	O
DNA-binding	O
activity	O
of	O
NF-kappaB	B-protein
.	O

Activation	O
of	O
NF-kappaB	B-protein
was	O
accompanied	O
by	O
degradation	O
of	O
its	O
cytosolic	B-protein
inhibitor	I-protein
IkappaB-alpha	I-protein
.	O

Blockade	O
of	O
depletion	O
of	O
IkappaB-alpha	B-protein
by	O
proteasome	O
inhibitors	O
(	O
proteasome	O
inhibitor	O
I	O
or	O
acetyl-leucinyl-leucinyl-norleucinal	O
)	O
led	O
to	O
concomitant	O
inhibition	O
of	O
NF-kappaB	O
DNA-binding	O
activity	O
and	O
expression	O
of	O
MIP-1alpha	B-RNA
and	I-RNA
MIP-1beta	I-RNA
messenger	I-RNA
RNA	I-RNA
induced	O
by	O
beta	O
(	O
2	O
)	O
integrin	O
ligation	O
.	O

These	O
results	O
suggest	O
that	O
triggering	O
of	O
CD11b	B-protein
or	O
CD11c	B-protein
beta	I-protein
(	I-protein
2	I-protein
)	I-protein
integrin	O
on	O
primary	B-cell_type
human	I-cell_type
monocytes	I-cell_type
provides	O
activation	O
signals	O
leading	O
to	O
nuclear	O
translocation	O
of	O
NF-kappaB	B-protein
and	O
subsequent	O
secretion	O
of	O
MIP-1alpha	B-protein
and	O
MIP-1beta	B-protein
that	O
may	O
have	O
an	O
important	O
role	O
in	O
recruitment	O
of	O
other	O
inflammatory	B-cell_type
cells	I-cell_type
during	O
initiation	O
of	O
an	O
inflammatory	O
response	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHEMOKINES	NULL
Ligation	NULL
of	NULL
CD11b	NULL
and	NULL
CD11¢	NULL
B	NULL
;	NULL
integrins	NULL
by	NULL
antibodies	NULL
or	NULL
soluble	NULL
CD23	NULL
induces	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
«	NULL
(	NULL
MIP-1	NULL
«	NULL
)	NULL
and	NULL
MIP-1	NULL
production	NULL
in	NULL
primary	NULL
human	NULL
monocytes	NULL
through	NULL
a	NULL
pathway	NULL
dependent	NULL
on	NULL
nuclear	NULL
factor-	NULL
B	NULL
Roger	NULL
Rezzonico	NULL
,	NULL
Veronique	NULL
Imbert	NULL
,	NULL
Rachel	NULL
Chicheportiche	NULL
,	NULL
and	NULL
Jean-Michel	NULL
Dayer	NULL
Chemokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
such	NULL
as	NULL
integrins	NULL
play	NULL
a	NULL
major	NULL
part	NULL
in	NULL
the	NULL
trafficking	NULL
,	NULL
extravasation	NULL
,	NULL
and	NULL
recruitment	NULL
of	NULL
leukocytes	NULL
to	NULL
inflammatory	NULL
sites	NULL
.	NULL

This	NULL
study	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
on	NULL
chemokine	NULL
production	NULL
by	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
.	NULL

We	NULL
found	NULL
that	NULL
ligation	NULL
of	NULL
CD11b	NULL
or	NULL
CD11c	NULL
but	NULL
not	NULL
CD1ia	NULL
«	NULL
chains	NULL
of	NULL
B	NULL
;	NULL
integrins	NULL
by	NULL
antibodies	NULL
or	NULL
soluble	NULL
CD23	NULL
(	NULL
sCD23	NULL
)	NULL
fusion	NULL
proteins	NULL
rapidly	NULL
induced	NULL
transcription	NULL
and	NULL
secretion	NULL
of	NULL
interleukin	NULL
8	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
1a	NULL
,	NULL
and	NULL
MIP-18B	NULL
.	NULL

Because	NULL
the	NULL
promoters	NULL
of	NULL
these	NULL
chemokine	NULL
genes	NULL
contain	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
possible	NULL
role	NULL
of	NULL
nuclear	NULL
factor-kB	NULL
in	NULL
controlling	NULL
induction	NULL
of	NULL
the	NULL
genes	NULL
through	NULL
B	NULL
»	NULL
integrin	NULL
engagement	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
showed	NULL
that	NULL
sCD23	NULL
or	NULL
antibodies	NULL
to	NULL
CD11b	NULL
or	NULL
to	NULL
CD1ic	NULL
up-regulated	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
.	NULL

Activation	NULL
of	NULL
NF-kB	NULL
was	NULL
accompanied	NULL
by	NULL
degradation	NULL
of	NULL
its	NULL
cytosolic	NULL
inhibitor	NULL
IkB-	NULL
«	NULL
.	NULL

Blockade	NULL
of	NULL
depletion	NULL
of	NULL
IkB-	NULL
«	NULL
by	NULL
proteasome	NULL
inhibitors	NULL
(	NULL
proteasome	NULL
inhibitor	NULL
|	NULL
or	NULL
acetyl-leucinyl-leucinyl-norleuci-nal	NULL
)	NULL
led	NULL
to	NULL
concomitant	NULL
inhibition	NULL
of	NULL
NF-B	NULL
DNA-binding	NULL
activity	NULL
and	NULL
expression	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1B	NULL
messenger	NULL
RNA	NULL
induced	NULL
by	NULL
B	NULL
;	NULL
integrin	NULL
ligation	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
triggering	NULL
of	NULL
CD11b	NULL
or	NULL
CD1lic	NULL
B	NULL
,	NULL
integrin	NULL
on	NULL
primary	NULL
human	NULL
monocytes	NULL
provides	NULL
activation	NULL
signals	NULL
leading	NULL
to	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
and	NULL
subsequent	NULL
secretion	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-186	NULL
that	NULL
may	NULL
have	NULL
an	NULL
important	NULL
role	NULL
in	NULL
recruitment	NULL
of	NULL
other	NULL
inflammatory	NULL
cells	NULL
during	NULL
initiation	NULL
of	NULL
an	NULL
inflammatory	NULL
response	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2001	NULL
;	NULL
97:2932-2940	NULL
)	NULL
©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
Recruitment	NULL
of	NULL
circulating	NULL
leukocytes	NULL
to	NULL
an	NULL
inflammatory	NULL
site	NULL
in	NULL
response	NULL
to	NULL
stimuli	NULL
such	NULL
as	NULL
infectious	NULL
agents	NULL
(	NULL
viruses	NULL
,	NULL
bacteria	NULL
,	NULL
and	NULL
protozoans	NULL
)	NULL
or	NULL
noninfectious	NULL
processes	NULL
(	NULL
trauma	NULL
,	NULL
autoimmune	NULL
disor-ders	NULL
,	NULL
and	NULL
ischemia-reperfusion	NULL
injury	NULL
)	NULL
is	NULL
a	NULL
crucial	NULL
step	NULL
in	NULL
the	NULL
development	NULL
of	NULL
both	NULL
acute	NULL
and	NULL
chronic	NULL
inflammatory	NULL
responses	NULL
.	NULL

In	NULL
all	NULL
these	NULL
conditions	NULL
,	NULL
extravasation	NULL
of	NULL
circulating	NULL
leukocytes	NULL
requires	NULL
communication	NULL
with	NULL
vascular	NULL
endothelial	NULL
cells	NULL
that	NULL
in	NULL
turn	NULL
depends	NULL
on	NULL
an	NULL
interrelated	NULL
network	NULL
of	NULL
events	NULL
involving	NULL
the	NULL
finely	NULL
regulated	NULL
action	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
(	NULL
ie	NULL
,	NULL
interleukin	NULL
[	NULL
IL	NULL
]	NULL
1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
[	NULL
TNF	NULL
]	NULL
-	NULL
«	NULL
@	NULL
)	NULL
,	NULL
adhesion	NULL
molecules	NULL
(	NULL
notably	NULL
integrins	NULL
)	NULL
,	NULL
and	NULL
chemoattractant	NULL
cytokines	NULL
called	NULL
chemokines	NULL
.	NULL

Chemokines	NULL
are	NULL
highly	NULL
conserved	NULL
,	NULL
small	NULL
,	NULL
secreted	NULL
or	NULL
membrane-bound	NULL
cytokines	NULL
with	NULL
molecular	NULL
masses	NULL
of	NULL
6	NULL
to	NULL
14	NULL
kd	NULL
and	NULL
a	NULL
characteristic	NULL
4-cysteine	NULL
motif	NULL
in	NULL
their	NULL
amino	NULL
acid	NULL
sequence	NULL
.	NULL

!	NULL
``	NULL

Two	NULL
main	NULL
subfami-lies	NULL
are	NULL
defined	NULL
according	NULL
to	NULL
the	NULL
position	NULL
of	NULL
the	NULL
first	NULL
2	NULL
cysteine	NULL
residues	NULL
.	NULL

In	NULL
the	NULL
CXC	NULL
(	NULL
or	NULL
a-chemokine	NULL
)	NULL
subfamily	NULL
,	NULL
these	NULL
residues	NULL
are	NULL
separated	NULL
by	NULL
one	NULL
amino	NULL
acid	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
CC	NULL
(	NULL
or	NULL
B-chemokine	NULL
)	NULL
subfamily	NULL
,	NULL
they	NULL
are	NULL
adjacent	NULL
.	NULL

The	NULL
B-chemokines	NULL
,	NULL
which	NULL
include	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
1	NULL
(	NULL
MCP-1	NULL
)	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
1a	NULL
,	NULL
MIP-16B	NULL
,	NULL
and	NULL
regulated	NULL
on	NULL
activation	NULL
,	NULL
normal	NULL
T-cell	NULL
expressed	NULL
and	NULL
secreted	NULL
(	NULL
RANTES	NULL
)	NULL
molecules	NULL
,	NULL
are	NULL
potent	NULL
chemotactic	NULL
agents	NULL
for	NULL
monocytes	NULL
.	NULL

*	NULL
``	NULL
The	NULL
migratory	NULL
behavior	NULL
of	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
a	NULL
concentration	NULL
gradient	NULL
of	NULL
these	NULL
soluble	NULL
chemotactic	NULL
factors	NULL
also	NULL
depends	NULL
on	NULL
adhesion	NULL
molecules	NULL
,	NULL
particularly	NULL
the	NULL
leukocyte-specific	NULL
3	NULL
;	NULL
integrins	NULL
.	NULL

Integrins	NULL
are	NULL
part	NULL
of	NULL
a	NULL
family	NULL
of	NULL
heterodimeric	NULL
transmembrane	NULL
glycoproteins	NULL
that	NULL
recognize	NULL
a	NULL
variety	NULL
of	NULL
ligands	NULL
or	NULL
counterreceptors	NULL
,	NULL
including	NULL
extracellular	NULL
matrix	NULL
and	NULL
cell-surface	NULL
and	NULL
plasma	NULL
proteins	NULL
,	NULL
and	NULL
that	NULL
consequently	NULL
control	NULL
numerous	NULL
physiologic	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
adhesion	NULL
,	NULL
locomotion	NULL
,	NULL
chemotaxis	NULL
,	NULL
and	NULL
phagocy-tosis.©	NULL
Expression	NULL
of	NULL
B	NULL
;	NULL
integrins	NULL
is	NULL
restricted	NULL
to	NULL
leukocytes	NULL
,	NULL
with	NULL
distribution	NULL
varying	NULL
among	NULL
leukocyte	NULL
subtypes	NULL
.	NULL

The	NULL
B	NULL
;	NULL
integrins	NULL
share	NULL
a	NULL
common	NULL
B	NULL
chain	NULL
(	NULL
CD18	NULL
)	NULL
and	NULL
have	NULL
at	NULL
least	NULL
4	NULL
distinct	NULL
«	NULL
chains	NULL
noncovalently	NULL
associated	NULL
with	NULL
CD18	NULL
:	NULL
lymphocyte	NULL
functional	NULL
antigen	NULL
1	NULL
(	NULL
«	NULL
B	NULL
;	NULL
CD112	NULL
@	NULL
/CD18	NULL
)	NULL
,	NULL
macrophage	NULL
antigen	NULL
1	NULL
(	NULL
Mac-1	NULL
;	NULL
CR3	NULL
,	NULL
CD11b/CD18	NULL
)	NULL
,	NULL
p150,95	NULL
(	NULL
axB	NULL
;	NULL
,	NULL
CR4	NULL
,	NULL
CD11c/	NULL
CD18	NULL
)	NULL
,	NULL
and	NULL
a	NULL
newly	NULL
characterized	NULL
member	NULL
,	NULL
opB	NULL
;	NULL
,	NULL
(	NULL
CD11d4/	NULL
CD18	NULL
)	NULL
.	NULL
``	NULL

''	NULL
Interestingly	NULL
,	NULL
some	NULL
chemokines	NULL
(	NULL
MCP-1	NULL
,	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-1B	NULL
,	NULL
and	NULL
RANTES	NULL
)	NULL
increase	NULL
surface	NULL
expression	NULL
of	NULL
CD11b/CD18	NULL
and	NULL
CD11c/CD18	NULL
on	NULL
human	NULL
monocytes	NULL
.	NULL

!	NULL

*	NULL
!	NULL

2	NULL
The	NULL
best	NULL
characterized	NULL
ligands	NULL
of	NULL
CD11a/CD18	NULL
are	NULL
intracellular	NULL
adhesion	NULL
molecule	NULL
(	NULL
ICAM	NULL
)	NULL
1	NULL
(	NULL
CD54	NULL
)	NULL
,	NULL
ICAM-2	NULL
(	NULL
CD102	NULL
)	NULL
,	NULL
and	NULL
ICAM-3	NULL
(	NULL
CD50	NULL
)	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
members	NULL
of	NULL
the	NULL
immunoglobulin	NULL
superfamily	NULL
.	NULL
'	NULL

''	NULL
``	NULL
CD11b/CD18	NULL
also	NULL
binds	NULL
to	NULL
ICAM-1	NULL
and	NULL
other	NULL
soluble	NULL
ligands	NULL
,	NULL
including	NULL
fibrinogen	NULL
,	NULL
complement	NULL
fragment	NULL
iC3b	NULL
,	NULL
coagulation	NULL
factor	NULL
X	NULL
,	NULL
arginine-glycine-aspartic	NULL
acid	NULL
sequences	NULL
,	NULL
heparin-like	NULL
glycosaminoglycans	NULL
,	NULL
certain	NULL
forms	NULL
of	NULL
collagen	NULL
,	NULL
and	NULL
bacterial	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
.	NULL
``	NULL

The	NULL
functional	NULL
role	NULL
and	NULL
ligands	NULL
of	NULL
CD11¢/CD18	NULL
have	NULL
not	NULL
been	NULL
well	NULL
defined	NULL
but	NULL
appear	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
Mac-1	NULL
,	NULL
ie	NULL
,	NULL
implicated	NULL
in	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
endothelium	NULL
``	NULL
©	NULL
and	NULL
binding	NULL
to	NULL
iC3b	NULL
,	NULL
fibrinogen	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
type	NULL
I	NULL
collagen	NULL
.	NULL

``	NULL
``	NULL
3	NULL
``	NULL
Human	NULL
CD23	NULL
,	NULL
the	NULL
low-affinity	NULL
receptor	NULL
for	NULL
IgE	NULL
(	NULL
FeeRIN	NULL
)	NULL
,	NULL
is	NULL
a	NULL
45-kd	NULL
type	NULL
II	NULL
membrane	NULL
glycoprotein	NULL
expressed	NULL
on	NULL
many	NULL
hematopoietic	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
B	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
.	NULL

CD23	NULL
is	NULL
cleaved	NULL
into	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Immunology	NULL
and	NULL
Allergy	NULL
,	NULL
Clinical	NULL
Immunology	NULL
Unit	NULL
(	NULL
Hans	NULL
Wilsdorf	NULL
Laboratory	NULL
)	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
Hospital	NULL
,	NULL
Geneva	NULL
,	NULL
Switzerland	NULL
;	NULL
and	NULL
INSERM	NULL
U526	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
,	NULL
Nice	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
September	NULL
14	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
January	NULL
7	NULL
,	NULL
2001	NULL
.	NULL

Reprints	NULL
:	NULL
Roger	NULL
Rezzonico	NULL
,	NULL
INSERM	NULL
U364	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
,	NULL
Avenue	NULL
de	NULL
2932	NULL
Valombrose	NULL
,	NULL
06107	NULL
Nice	NULL
Cedex	NULL
02	NULL
,	NULL
France	NULL
;	NULL
e-mail	NULL
:	NULL
rezzonic	NULL
@	NULL
unice.fr	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
biologically	NULL
active	NULL
soluble	NULL
fragments	NULL
(	NULL
s€CD23	NULL
)	NULL
,	NULL
and	NULL
this	NULL
results	NULL
in	NULL
generation	NULL
of	NULL
a	NULL
relatively	NULL
stable	NULL
25-kd	NULL
fragment	NULL
.	NULL
``	NULL

CD23	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
IgE-	NULL
or	NULL
CD21-dependent	NULL
biologic	NULL
activities	NULL
,	NULL
such	NULL
as	NULL
cell-cell	NULL
adhesion	NULL
,	NULL
B-cell	NULL
survival	NULL
in	NULL
germinal	NULL
centers	NULL
,	NULL
histamine	NULL
release	NULL
from	NULL
basophils	NULL
,	NULL
and	NULL
regulation	NULL
of	NULL
IgE	NULL
production	NULL
.	NULL
``	NULL

''	NULL
It	NULL
was	NULL
also	NULL
reported	NULL
that	NULL
CD23	NULL
is	NULL
a	NULL
functional	NULL
ligand	NULL
for	NULL
CD11b	NULL
and	NULL
CD11c	NULL
on	NULL
human	NULL
and	NULL
murine	NULL
monocytes	NULL
.	NULL
``	NULL

``	NULL
``	NULL
Although	NULL
B	NULL
;	NULL
,	NULL
integrins	NULL
promote	NULL
cellular	NULL
adhesion	NULL
in	NULL
various	NULL
immune-inflammatory	NULL
processes	NULL
,	NULL
they	NULL
also	NULL
function	NULL
like	NULL
most	NULL
transmembrane	NULL
receptors	NULL
that	NULL
are	NULL
capable	NULL
of	NULL
transmitting	NULL
outside-in	NULL
signals	NULL
elicited	NULL
by	NULL
ligand	NULL
binding	NULL
and	NULL
resulting	NULL
in	NULL
cellular	NULL
effector	NULL
responses	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
triggering	NULL
of	NULL
3	NULL
;	NULL
integrins	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
mAbs	NULL
)	NULL
or	NULL
s€D23	NULL
leads	NULL
to	NULL
production	NULL
of	NULL
nitric	NULL
oxide	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
(	NULL
TNF-	NULL
@	NULL
,	NULL
IL-1B	NULL
,	NULL
and	NULL
IL-6	NULL
)	NULL
,	NULL
induction	NULL
of	NULL
procoagulant	NULL
activity	NULL
,	NULL
and	NULL
up-regulation	NULL
of	NULL
cell-surface	NULL
molecule	NULL
expression	NULL
.	NULL

``	NULL
*	NULL
``	NULL
4	NULL
``	NULL
Such	NULL
interactions	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
,	NULL
including	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
,	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
,	NULL
Sjégren	NULL
syndrome	NULL
,	NULL
glomerulonephri-tis	NULL
,	NULL
and	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
in	NULL
which	NULL
increased	NULL
levels	NULL
of	NULL
CD23	NULL
have	NULL
been	NULL
observed	NULL
.	NULL
``	NULL

However	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
intracellular	NULL
events	NULL
regulating	NULL
these	NULL
cell	NULL
functions	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
previously	NULL
analyzed	NULL
the	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
IL-1	NULL
B	NULL
production	NULL
with	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
on	NULL
human	NULL
monocytes	NULL
.	NULL

*	NULL
Because	NULL
interaction	NULL
of	NULL
monocytes	NULL
with	NULL
endothelial	NULL
cells	NULL
results	NULL
in	NULL
chemokine	NULL
production	NULL
,	NULL
``	NULL
``	NULL
we	NULL
here	NULL
investigated	NULL
the	NULL
mechanisms	NULL
controlling	NULL
production	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1	NULL
§	NULL
(	NULL
members	NULL
of	NULL
the	NULL
CC	NULL
chemokine	NULL
subfamily	NULL
)	NULL
by	NULL
primary	NULL
human	NULL
monocytes	NULL
activated	NULL
through	NULL
CD11b	NULL
or	NULL
CD11c	NULL
3	NULL
;	NULL
integrin	NULL
engagement	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Reagents	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
penicillin	NULL
,	NULL
strepto-mycin	NULL
,	NULL
and	NULL
L-glutamine	NULL
were	NULL
supplied	NULL
by	NULL
Life	NULL
Technologies	NULL
(	NULL
Paisley	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

Low-endotoxin	NULL
fetal-calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
was	NULL
from	NULL
Se-romed	NULL
(	NULL
Biochrom	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
Ficoll-Paque	NULL
device	NULL
was	NULL
from	NULL
Pharmacia	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Polymyxin	NULL
B	NULL
sulfate	NULL
,	NULL
neuraminidase	NULL
,	NULL
N-acetyl-leucinyl-leucinyl-norleucinal	NULL
(	NULL
ALLN	NULL
)	NULL
,	NULL
and	NULL
all	NULL
other	NULL
chemicals	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

The	NULL
«	NULL
-phosphorus	NULL
32	NULL
(	NULL
°°P	NULL
)	NULL
uridine	NULL
triphosphate	NULL
(	NULL
1.11°	NULL
GBq	NULL
[	NULL
3000	NULL
Ci	NULL
]	NULL
/mmol	NULL
)	NULL
was	NULL
from	NULL
Hartmann	NULL
Analytic	NULL
(	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Proteasome	NULL
inhibitor	NULL
I	NULL
(	NULL
PST	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
human	NULL
recombinant	NULL
TNF-	NULL
«	NULL
from	NULL
Biogen	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
soluble	NULL
TNF	NULL
receptor	NULL
(	NULL
sTNFR	NULL
)	NULL
-p55	NULL
from	NULL
Amgen	NULL
(	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Culture	NULL
media	NULL
contained	NULL
less	NULL
than	NULL
0.15	NULL
U/mL	NULL
endotoxin	NULL
on	NULL
chromogenic	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
.	NULL

mAbs	NULL
and	NULL
recombinant	NULL
chimeric	NULL
proteins	NULL
Anti-CD11a	NULL
were	NULL
from	NULL
the	NULL
Binding	NULL
Site	NULL
(	NULL
Birmingham	NULL
,	NULL
United	NULL
Kingdom	NULL
;	NULL
IgG1	NULL
,	NULL
clone	NULL
BU17	NULL
)	NULL
and	NULL
Pharmingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
;	NULL
IgG2b	NULL
,	NULL
clone	NULL
G43-25B	NULL
)	NULL
.	NULL

Anti-CD11b	NULL
were	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
;	NULL
IgG1	NULL
,	NULL
clone	NULL
44	NULL
)	NULL
and	NULL
Serotec	NULL
(	NULL
Oxford	NULL
,	NULL
United	NULL
Kingdom	NULL
;	NULL
IgG1	NULL
,	NULL
clone	NULL
ICRFA44	NULL
)	NULL
.	NULL

Anti-CD11c	NULL
were	NULL
from	NULL
the	NULL
Binding	NULL
Site	NULL
(	NULL
IgG1	NULL
;	NULL
clone	NULL
BU15	NULL
)	NULL
and	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
IgG1	NULL
,	NULL
clone	NULL
3.9	NULL
)	NULL
.	NULL

The	NULL
isotype	NULL
mAb	NULL
controls	NULL
were	NULL
from	NULL
Pharmingen	NULL
.	NULL

Human	NULL
recombinant	NULL
fusion	NULL
proteins	NULL
for	NULL
s€CD23	NULL
were	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
M.	NULL
Bird	NULL
(	NULL
Glaxo	NULL
Wellcome	NULL
,	NULL
Stevenage	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

The	NULL
human	NULL
fusion	NULL
protein	NULL
ZZ-CD23	NULL
consists	NULL
of	NULL
the	NULL
lectin	NULL
domain	NULL
of	NULL
human	NULL
CD23	NULL
linked	NULL
to	NULL
the	NULL
protein	NULL
A	NULL
IgG	NULL
binding	NULL
domain	NULL
(	NULL
ZZ	NULL
)	NULL
and	NULL
is	NULL
produced	NULL
in	NULL
insect	NULL
cells	NULL
as	NULL
described	NULL
previ-ously	NULL
.	NULL

*	NULL
ZZ-CD23	NULL
can	NULL
form	NULL
oligomers	NULL
in	NULL
solution	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
polymeric	NULL
ZZ-CD23	NULL
purified	NULL
by	NULL
gel	NULL
filtration	NULL
as	NULL
described	NULL
previously	NULL
for	NULL
mouse	NULL
ZZ-CD23.°	NULL
ZZ-P	NULL
selectin	NULL
and	NULL
ZZ-E	NULL
selectin	NULL
fusion	NULL
proteins	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

MBP-CD23	NULL
chimeric	NULL
protein	NULL
consists	NULL
of	NULL
maltose	NULL
binding	NULL
protein	NULL
fused	NULL
to	NULL
the	NULL
C-terminal	NULL
25-kd	NULL
form	NULL
of	NULL
human	NULL
CD23	NULL
.	NULL

It	NULL
was	NULL
expressed	NULL
in	NULL
soluble	NULL
form	NULL
in	NULL
Escherichia	NULL
coli	NULL
,	NULL
purified	NULL
by	NULL
affinity	NULL
chromatog-	NULL
B	NULL
»	NULL
INTEGRIN	NULL
LIGATION	NULL
CONTROLS	NULL
CHEMOKINE	NULL
SYNTHESIS	NULL
_	NULL
2933	NULL
raphy	NULL
on	NULL
amylose	NULL
resin	NULL
,	NULL
and	NULL
processed	NULL
to	NULL
remove	NULL
endotoxin	NULL
by	NULL
repeated	NULL
passage	NULL
through	NULL
Detoxi-gel	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
monocytes	NULL
Monocytes	NULL
from	NULL
fresh	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
volunteers	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
isolated	NULL
by	NULL
using	NULL
a	NULL
Ficoll	NULL
density	NULL
gradient	NULL
were	NULL
incubated	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
50	NULL
X	NULL
105	NULL
cells/mL	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
for	NULL
40	NULL
minutes	NULL
at	NULL
4°C	NULL
,	NULL
with	NULL
rotation	NULL
leading	NULL
to	NULL
monocyte	NULL
aggregation	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
10	NULL
minutes	NULL
of	NULL
incubation	NULL
on	NULL
ice	NULL
.	NULL

Pellets	NULL
of	NULL
aggregated	NULL
enriched	NULL
monocytes	NULL
were	NULL
separated	NULL
from	NULL
nonaggregated	NULL
PBMC	NULL
by	NULL
a	NULL
gradient	NULL
using	NULL
FCS	NULL
.	NULL

Enriched	NULL
monocyte	NULL
preparations	NULL
were	NULL
further	NULL
depleted	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
by	NULL
rosetting	NULL
with	NULL
neuraminidase-treated	NULL
sheep	NULL
red	NULL
blood	NULL
cells	NULL
.	NULL

Final	NULL
monocyte	NULL
preparations	NULL
routinely	NULL
contained	NULL
more	NULL
than	NULL
90	NULL
%	NULL
CD14*	NULL
cells	NULL
,	NULL
less	NULL
than	NULL
1	NULL
%	NULL
CD3*	NULL
cells	NULL
,	NULL
and	NULL
less	NULL
than	NULL
1	NULL
%	NULL
CD19*	NULL
cells	NULL
.	NULL

Cellular	NULL
viability	NULL
was	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
on	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Polymyxin	NULL
B	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
was	NULL
present	NULL
throughout	NULL
the	NULL
isolation	NULL
procedure	NULL
and	NULL
during	NULL
activation	NULL
experiments	NULL
to	NULL
rule	NULL
out	NULL
contamination	NULL
by	NULL
low	NULL
levels	NULL
of	NULL
endotoxin	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
to	NULL
prevent	NULL
activation	NULL
on	NULL
adhesion	NULL
,	NULL
monocytes	NULL
were	NULL
cultured	NULL
and	NULL
stimulated	NULL
in	NULL
polypropylene	NULL
tubes	NULL
unless	NULL
indicated	NULL
otherwise	NULL
.	NULL

Monocyte	NULL
activation	NULL
and	NULL
measurement	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1§6	NULL
Freshly	NULL
isolated	NULL
monocytes	NULL
were	NULL
cultured	NULL
in	NULL
flat-bottomed	NULL
,	NULL
96-well	NULL
tissue-culture	NULL
trays	NULL
(	NULL
Corning	NULL
Costar	NULL
,	NULL
Kennebunk	NULL
,	NULL
ME	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
50	NULL
X	NULL
10°	NULL
cells/well	NULL
in	NULL
complete	NULL
RPMI	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
polymyxin	NULL
B.	NULL
Monocytes	NULL
were	NULL
cultured	NULL
for	NULL
various	NULL
times	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-	NULL
;	NULL
integrin	NULL
mAbs	NULL
or	NULL
recombinant	NULL
s€CD23	NULL
fusion	NULL
proteins	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
then	NULL
tested	NULL
for	NULL
production	NULL
of	NULL
MIP-l	NULL
«	NULL
and	NULL
MIP-1B	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assays	NULL
(	NULL
ELISA	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Abingdon	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

The	NULL
limits	NULL
of	NULL
detection	NULL
were	NULL
10	NULL
pg/mL	NULL
and	NULL
4	NULL
pg/mL	NULL
,	NULL
respectively	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
RNase	NULL
protection	NULL
assays	NULL
Human	NULL
monocytes	NULL
(	NULL
5-10	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
starved	NULL
for	NULL
14	NULL
hours	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
FCS	NULL
in	NULL
polypropylene	NULL
tubes	NULL
(	NULL
Falcon	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
resus-pended	NULL
in	NULL
500	NULL
wL	NULL
RPMI	NULL
and	NULL
HEPES	NULL
containing	NULL
1	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
2-mL	NULL
tubes	NULL
(	NULL
Eppendorf	NULL
,	NULL
Germany	NULL
)	NULL
at	NULL
37°C	NULL
with	NULL
or	NULL
without	NULL
effectors	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
lysing	NULL
the	NULL
cells	NULL
with	NULL
Trizol	NULL
reagent	NULL
(	NULL
Life	NULL
Technolo-gies	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-18B	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
messenger	NULL
RNA	NULL
(	NULL
mRNAs	NULL
)	NULL
by	NULL
RiboQuant	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
RPA	NULL
)	NULL
using	NULL
the	NULL
hck-5	NULL
multiprobe	NULL
template	NULL
set	NULL
from	NULL
Pharmingen	NULL
.	NULL

Briefly	NULL
,	NULL
riboprobes	NULL
were	NULL
labeled	NULL
with	NULL
and	NULL
hybridized	NULL
overnight	NULL
in	NULL
solution	NULL
with	NULL
1	NULL
to	NULL
2	NULL
ug	NULL
RNA	NULL
.	NULL

The	NULL
hybridized	NULL
RNA	NULL
was	NULL
digested	NULL
with	NULL
RNase	NULL
,	NULL
and	NULL
the	NULL
remaining	NULL
``	NULL
RNase-protected	NULL
``	NULL
probes	NULL
were	NULL
purified	NULL
,	NULL
resolved	NULL
on	NULL
denaturating	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
imaged	NULL
autora-diographically	NULL
according	NULL
to	NULL
the	NULL
RiboQuant	NULL
protocol	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Nonadherent	NULL
monocytes	NULL
were	NULL
starved	NULL
for	NULL
14	NULL
hours	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
FCS	NULL
in	NULL
polypropylene	NULL
tubes	NULL
,	NULL
and	NULL
7	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
various	NULL
times	NULL
in	NULL
2-mL	NULL
polypropylene	NULL
tubes	NULL
at	NULL
37°C	NULL
with	NULL
or	NULL
without	NULL
effectors	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
monocytes	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
1	NULL
mL	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
which	NULL
consisted	NULL
of	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
sodium	NULL
chloride	NULL
(	NULL
NaC	NULL
]	NULL
)	NULL
,	NULL
0.8	NULL
mM	NULL
magnesium	NULL
chloride	NULL
,	NULL
5	NULL
mM	NULL
ethylene	NULL
glycol	NULL
tetraacetic	NULL
acid	NULL
(	NULL
EGTA	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P40	NULL
(	NULL
NP-40	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
phenylmethyl	NULL
sulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
15	NULL
pg/mL	NULL
leupeptin	NULL
,	NULL
1	NULL
M	NULL
pepstatin	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
fluorescein	NULL
(	NULL
NaF	NULL
)	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
(	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
)	NULL
.	NULL

The	NULL
crude	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
15	NULL
000g	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
in	NULL
the	NULL
supernatants	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
Bradford	NULL
reagent	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
total	NULL
cell	NULL
lysates	NULL
(	NULL
50	NULL
jug	NULL
proteins	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
Hybond	NULL
electrogenerated	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
membrane	NULL
(	NULL
Amersham	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
anti-IxB-a	NULL
polyclonal	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Secondary	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2934	NULL
REZZONICO	NULL
et	NULL
al	NULL
A	NULL
Anti-CD11b	NULL
B	NULL
Anti-CD11c	NULL
C	NULL
Anti-CD11a	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
.	NULL

o	NULL
15	NULL
30	NULL
45	NULL
60	NULL
120	NULL
240	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
.	NULL

o	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
60	NULL
MIP-16	NULL
4m	NULL
Ovi	NULL
-	NULL
1119-13	NULL
-p	NULL
MIP-16	NULL
g	NULL
»	NULL
MIP-1	NULL
c	NULL
#	NULL
>	NULL
a	NULL
MIP-1	NULL
c	NULL
#	NULL
>	NULL
MIP-10	NULL
#	NULL
>	NULL
>	NULL
@	NULL
@	NULL
=	NULL
1s	NULL
»	NULL
IL-8	NULL
47	NULL
>	NULL
GAPDH	NULL
Ap	NULL
@	NULL
rem	NULL
ms	NULL
eme	NULL
.	NULL

GAPDH	NULL
-p	NULL
GAPDH	NULL
-g	NULL
»	NULL
.	NULL

@	NULL
#	NULL
illh	NULL
MBP-CD23	NULL
ZZ-C023	NULL
ZZ-P	NULL
selectin	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
.	NULL

0	NULL
30	NULL
45	NULL
60	NULL
120	NULL
240	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
-	NULL
0	NULL
15	NULL
30	NULL
45	NULL
60120240	NULL
_	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
60	NULL
MIP-10	NULL
4	NULL
»	NULL
-	NULL
@	NULL
@	NULL
@	NULL
-	NULL
-p	NULL
-	NULL
MIP-1	NULL
(	NULL
-z	NULL
>	NULL
#	NULL
MIP-1	NULL
0	NULL
#	NULL
>	NULL
ﬂ	NULL
MIP-1	NULL
o	NULL
i	NULL
>	NULL
*	NULL
MIP-10	NULL
#	NULL
>	NULL
IL-8g	NULL
>	NULL
ﬂ	NULL
IL-8	NULL
z	NULL
»	NULL
U	NULL
‘	NULL
is	NULL
»	NULL
wan	NULL
GAPDH-pp	NULL
@	NULL
-	NULL
«	NULL
»	NULL
«	NULL
»	NULL
cme	NULL
GAPDH-	NULL
‘	NULL
wm	NULL
.	NULL

GAPDH	NULL
B	NULL
>	NULL
|	NULL
@	NULL
r	NULL
Figure	NULL
1	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-16	NULL
mRNA	NULL
induction	NULL
by	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
.	NULL

Nonadherent	NULL
human	NULL
monocytes	NULL
(	NULL
7	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
stimulated	NULL
for	NULL
various	NULL
times	NULL
with	NULL
the	NULL
following	NULL
effectors	NULL
:	NULL
anti-CD11b	NULL
(	NULL
ICRF44	NULL
,	NULL
2	NULL
ug/mL	NULL
;	NULL
A	NULL
)	NULL
anti-CD1ic	NULL
(	NULL
BU15	NULL
,	NULL
2	NULL
pg/mL	NULL
;	NULL
B	NULL
)	NULL
,	NULL
anti-CD1ia	NULL
(	NULL
BU17	NULL
,	NULL
2	NULL
pg/mL	NULL
;	NULL
C	NULL
)	NULL
MBP-CD23	NULL
(	NULL
1	NULL
pg/mL	NULL
;	NULL
D	NULL
)	NULL
Z2-CD23	NULL
(	NULL
1	NULL
mg/mL	NULL
;	NULL
E	NULL
)	NULL
,	NULL
and	NULL
ZZ-P	NULL
selectin	NULL
(	NULL
5	NULL
pg/mL	NULL
;	NULL
F	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
RPA	NULL
for	NULL
expression	NULL
of	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-18	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
GAPDH	NULL
mRNAs	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
2	NULL
distinct	NULL
experiments	NULL
.	NULL

horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
antirabbit	NULL
antibody	NULL
was	NULL
supplied	NULL
by	NULL
Dako	NULL
(	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

Antibody-bound	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
Amersham	NULL
ECL	NULL
system	NULL
.	NULL

Autoradiographic	NULL
results	NULL
were	NULL
quantified	NULL
by	NULL
densitometric	NULL
scanning	NULL
on	NULL
a	NULL
laser	NULL
densitometer	NULL
equipped	NULL
with	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Briefly	NULL
,	NULL
monocytes	NULL
(	NULL
10-15	NULL
X	NULL
108	NULL
cells	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
200	NULL
uL	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
potassium	NULL
chloride	NULL
[	NULL
KCI	NULL
]	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
raM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
15	NULL
g/mL	NULL
leupeptin	NULL
,	NULL
1	NULL
M	NULL
pepstatin	NULL
,	NULL
1	NULL
mM	NULL
NaF	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
)	NULL
containing	NULL
0.6	NULL
%	NULL
NP-40	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
centrifuged	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
from	NULL
pellets	NULL
in	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
kB	NULL
DNA	NULL
probe	NULL
(	NULL
5'-AGTTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
)	NULL
was	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnol-ogy	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
done	NULL
with	NULL
5	NULL
pg	NULL
nuclear	NULL
proteins	NULL
incubated	NULL
for	NULL
25	NULL
minutes	NULL
at	NULL
25°C	NULL
with	NULL
the	NULL
radiolabeled	NULL
xB	NULL
probe	NULL
(	NULL
25	NULL
000	NULL
epm	NULL
)	NULL
in	NULL
20	NULL
L	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
60	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mg/mL	NULL
bovine	NULL
serum	NULL
albumin	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
ng	NULL
poly	NULL
dI-dC	NULL
and	NULL
1	NULL
wg	NULL
sonicated	NULL
salmon-sperm	NULL
DNA	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
X	NULL
Tris-borate	NULL
EDTA	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
cold	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
B	NULL
or	NULL
the	NULL
unspecific	NULL
nuclear	NULL
factor	NULL
[	NULL
NF	NULL
]	NULL
1	NULL
consensus	NULL
binding	NULL
site	NULL
5-TTTTGGATTGAAGCCAATATGATAA-3	NULL
'	NULL
)	NULL
was	NULL
preincubated	NULL
for	NULL
15	NULL
minutes	NULL
with	NULL
nuclear	NULL
extracts	NULL
.	NULL

Results	NULL
Anti-CD11b	NULL
and	NULL
anti-CD11c	NULL
mAbs	NULL
and	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
are	NULL
potent	NULL
inducers	NULL
of	NULL
chemokine	NULL
mRNA	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
We	NULL
and	NULL
others**5848	NULL
previously	NULL
established	NULL
that	NULL
ligation	NULL
of	NULL
3	NULL
;	NULL
integrins	NULL
at	NULL
the	NULL
surface	NULL
of	NULL
human	NULL
monocytes	NULL
mediates	NULL
outside-in	NULL
signaling	NULL
leading	NULL
to	NULL
synthesis	NULL
and	NULL
secretion	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
notably	NULL
BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
IL-1B	NULL
.	NULL

Because	NULL
monocytes	NULL
are	NULL
also	NULL
an	NULL
important	NULL
source	NULL
of	NULL
chemokine	NULL
production	NULL
,	NULL
``	NULL
``	NULL
we	NULL
here	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
(	NULL
3	NULL
;	NULL
integrin	NULL
engagement	NULL
on	NULL
modulation	NULL
of	NULL
chemokine	NULL
expression	NULL
.	NULL

Enriched	NULL
human	NULL
monocytes	NULL
(	NULL
85	NULL
%	NULL
-90	NULL
%	NULL
CD14*	NULL
cells	NULL
)	NULL
were	NULL
starved	NULL
for	NULL
14	NULL
hours	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
FCS	NULL
and	NULL
then	NULL
cultured	NULL
under	NULL
nonadherent	NULL
conditions	NULL
in	NULL
polypropylene	NULL
tubes	NULL
for	NULL
15	NULL
minutes	NULL
to	NULL
4	NULL
hours	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
mAbs	NULL
raised	NULL
against	NULL
CD11a	NULL
,	NULL
CD11b	NULL
,	NULL
or	NULL
CD11¢	NULL
B	NULL
;	NULL
integrin	NULL
a	NULL
chains	NULL
or	NULL
s€CD23	NULL
chimeric	NULL
proteins	NULL
.	NULL

The	NULL
concentrations	NULL
used	NULL
were	NULL
those	NULL
previously	NULL
found	NULL
to	NULL
induce	NULL
IL-1	NULL
production	NULL
.	NULL
``	NULL

''	NULL
Cells	NULL
were	NULL
then	NULL
analyzed	NULL
for	NULL
chemokine	NULL
mRNA	NULL
expression	NULL
by	NULL
RPA	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
incubation	NULL
of	NULL
monocytes	NULL
with	NULL
anti-CD11b	NULL
or	NULL
anti-CD11¢	NULL
mAbs	NULL
led	NULL
rapidly	NULL
to	NULL
a	NULL
marked	NULL
induction	NULL
of	NULL
MIP-l	NULL
«	NULL
,	NULL
MIP-1fB	NULL
,	NULL
and	NULL
IL-8	NULL
mRNAs	NULL
.	NULL

These	NULL
were	NULL
detected	NULL
after	NULL
30	NULL
minutes	NULL
and	NULL
maintained	NULL
after	NULL
4	NULL
hours	NULL
of	NULL
activation	NULL
.	NULL

Similarly	NULL
,	NULL
stimulation	NULL
of	NULL
monocytes	NULL
by	NULL
2	NULL
distinct	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
,	NULL
MBP-CD23	NULL
and	NULL
ZZ-CD23	NULL
,	NULL
through	NULL
CD11b	NULL
and	NULL
CD11¢c	NULL
counterreceptors	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
potent	NULL
increase	NULL
in	NULL
steady-state	NULL
levels	NULL
of	NULL
MIP-la	NULL
,	NULL
MIP-1B	NULL
,	NULL
and	NULL
IL-8	NULL
mRNAs	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
induction	NULL
of	NULL
mRNAs	NULL
of	NULL
MCP-1	NULL
or	NULL
interferon-y-inducible	NULL
protein	NULL
10	NULL
(	NULL
IP-10	NULL
)	NULL
,	NULL
2	NULL
chemokines	NULL
produced	NULL
by	NULL
monocytes	NULL
under	NULL
different	NULL
activation	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
anti-CD11a	NULL
mAbs	NULL
and	NULL
ZZ-P	NULL
selectin	NULL
chimeric	NULL
protein	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
chemokine	NULL
mRNA	NULL
levels	NULL
(	NULL
Figure	NULL
1C	NULL
and	NULL
1F	NULL
)	NULL
,	NULL
as	NULL
was	NULL
already	NULL
reported	NULL
for	NULL
IL-1	NULL
synthesis	NULL
.	NULL

*	NULL
'	NULL
The	NULL
stimulatory	NULL
effect	NULL
of	NULL
B	NULL
;	NULL
integrin	NULL
triggering	NULL
on	NULL
chemokine	NULL
gene	NULL
expression	NULL
was	NULL
dose	NULL
dependent	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
monocytes	NULL
by	NULL
anti-CD11b	NULL
or	NULL
anti-CD11¢	NULL
mAbs	NULL
stimulated	NULL
MIP-1a	NULL
,	NULL
MIP-1B	NULL
,	NULL
and	NULL
IL-8	NULL
mRNAs	NULL
at	NULL
concentrations	NULL
as	NULL
low	NULL
as	NULL
0.2	NULL
to	NULL
0.5	NULL
g/mL	NULL
and	NULL
reached	NULL
maximal	NULL
levels	NULL
at	NULL
5	NULL
to	NULL
10	NULL
pg/mL	NULL
mAbs	NULL
.	NULL

Similarly	NULL
,	NULL
chemokine	NULL
mRNAs	NULL
were	NULL
induced	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
0.1	NULL
pg/mL	NULL
ZZ-CD23	NULL
or	NULL
MBP-CD23	NULL
fusion	NULL
proteins	NULL
and	NULL
maximal	NULL
activation	NULL
was	NULL
reached	NULL
with	NULL
2	NULL
to	NULL
5	NULL
g/mL	NULL
.	NULL

These	NULL
results	NULL
constitute	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
engagement	NULL
of	NULL
CD11b	NULL
and	NULL
CD11c	NULL
is	NULL
a	NULL
potent	NULL
and	NULL
selective	NULL
inducer	NULL
of	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-1fB	NULL
,	NULL
and	NULL
IL-8	NULL
mRNA	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

A	NULL
B	NULL
Anti-CD11b	NULL
(	NULL
ug/imL	NULL
)	NULL
0	NULL
0.20.5	NULL
1	NULL
2	NULL
5	NULL
Anti-CD11c	NULL
(	NULL
ug/ml	NULL
)	NULL
0	NULL
0.2	NULL
0.5	NULL
1	NULL
2	NULL
5	NULL
10	NULL
MIP-1f	NULL
}	NULL
-g	NULL
»	NULL
«	NULL
--	NULL
my	NULL
MIP-1f	NULL
)	NULL
-z	NULL
»	NULL
n	NULL
‘	NULL
MIP-1	NULL
«	NULL
ime	NULL
«	NULL
=	NULL
‘	NULL
J	NULL
MIP-1	NULL
0	NULL
-m	NULL
n	NULL
‘	NULL
IL-8	NULL
-gm	NULL
n	NULL
“	NULL
IL-8	NULL
-z	NULL
»	NULL
GAPDH	NULL
fi-	NULL
#	NULL
#	NULL
mm	NULL
mm	NULL
»	NULL
»	NULL
GAPDH	NULL
-mm	NULL
Mita	NULL
ans	NULL
onne	NULL
ZZ-CD23	NULL
(	NULL
ug/ml	NULL
)	NULL
0	NULL
0.10.5	NULL
1	NULL
5	NULL
MBP-CD23	NULL
(	NULL
ug/ml	NULL
)	NULL
0	NULL
0.1	NULL
0.5	NULL
2	NULL
MIP-A16	NULL
>	NULL
~d	NULL
MIP-16	NULL
-m	NULL
~	NULL
MIP-10	NULL
.	NULL

-g	NULL
»	NULL
sans	NULL
comm	NULL
lis	NULL
MIP-10	NULL
.	NULL

-	NULL
#	NULL
m	NULL
>	NULL
‘	NULL
IL-8	NULL
-	NULL
»	NULL
-	NULL
MMM	NULL
IL-8	NULL
z	NULL
»	NULL
‘	NULL
G	NULL
AP	NULL
DH	NULL
-B-	NULL
-	NULL
diia	NULL
as	NULL
GAPDH	NULL
-m	NULL
»	NULL
ca	NULL
cam	NULL
Figure	NULL
2	NULL
.	NULL

Dose-dependent	NULL
stimulatory	NULL
effect	NULL
of	NULL
anti-CD11b	NULL
and	NULL
anti-CD11c	NULL
mAbs	NULL
and	NULL
sCD23	NULL
chimeric	NULL
proteins	NULL
on	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-16	NULL
mRNAs	NULL
.	NULL

Monocytes	NULL
(	NULL
7	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
following	NULL
effectors	NULL
:	NULL
anti-CD11b	NULL
(	NULL
ICRF44	NULL
;	NULL
A	NULL
)	NULL
,	NULL
anti-CD11c	NULL
(	NULL
BU15	NULL
;	NULL
B	NULL
)	NULL
,	NULL
ZZ-CD23	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
MBP-CD23	NULL
(	NULL
D	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
for	NULL
expression	NULL
of	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-16	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
GAPDH	NULL
mRNAs	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
2	NULL
distinct	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
...	NULL
20	NULL
A	NULL
0	NULL
_	NULL
1°	NULL
MIP13	NULL
_	NULL
«	NULL
l	NULL
B	NULL
£	NULL
p	NULL
£15	NULL
g	NULL
7.5	NULL
ﬂ	NULL
S	NULL
7	NULL
F	NULL
B	NULL
7	NULL
©	NULL
d	NULL
&	NULL
10	NULL
§	NULL
5	NULL
y	NULL
,	NULL
$	NULL
F3	NULL
7	NULL
f	NULL
B	NULL
JG	NULL
Ios	NULL
T	NULL
as	NULL
¢	NULL
%	NULL
G	NULL
=	NULL
ﬁ/	NULL
o	NULL
ol	NULL
=-	NULL
PAPA	NULL
:	NULL
Eo	NULL
gos	NULL
a	NULL
e	NULL
g	NULL
a	NULL
S	NULL
E	NULL
p	NULL
S	NULL
2	NULL
®	NULL
8	NULL
8	NULL
5	NULL
3	NULL
%	NULL
C	NULL
T	NULL
c	NULL
8	NULL
8	NULL
T	NULL
3	NULL
$	NULL
EoE	NULL
56	NULL
8	NULL
|	NULL
s	NULL
©	NULL
A	NULL
A	NULL
A	NULL
o	NULL
o	NULL
®	NULL
T	NULL
8	NULL
8	NULL
8	NULL
9	NULL
8	NULL
{	NULL
2	NULL
O	NULL
Q	NULL
(	NULL
4	NULL
®	NULL
2	NULL
0	NULL
0	NULL
0	NULL
d	NULL
1	NULL
€	NULL
3	NULL
Ro	NULL
$	NULL
$	NULL
op	NULL
®	NULL
3	NULL
9	NULL
9	NULL
2	NULL
doy	NULL
®	NULL
s	NULL
z	NULL
z	NULL
m	NULL
s	NULL
zo	NULL
z	NULL
a	NULL
£	NULL
&	NULL
£	NULL
E	NULL
o	NULL
.	NULL

5	NULL
5	NULL
C	NULL
E	NULL
a.	NULL
N	NULL
j	NULL
8	NULL
-i-	NULL
1gGt	NULL
j	NULL
8	NULL
-i-	NULL
1gG1	NULL
E	NULL
-	NULL
&	NULL
-	NULL
Anti-CDHia	NULL
E	NULL
-A-	NULL
Ant-CD11a	NULL
E	NULL
!	NULL

-	NULL
@	NULL
-	NULL
Ant-CD11b	NULL
Cc	NULL
”	NULL
-	NULL
@	NULL
-	NULL
_	NULL
Ant-CD11b	NULL
5	NULL
6	NULL
Ant-CD11c	NULL
w	NULL
6	NULL
-	NULL
#	NULL
-	NULL
Anti-CDtc	NULL
3	NULL
-o-	NULL
mBP-cor3	NULL
3	NULL
-o-	NULL
mBr.cors	NULL
8	NULL
8	NULL
2	NULL
a	NULL
-q-	NULL
22-CD23	NULL
2	NULL
4	NULL
22-CD23	NULL
O	NULL
O	NULL
O	NULL
O	NULL
©	NULL
3	NULL
ao	NULL
.	NULL

2	NULL
°	NULL
a	NULL
?	NULL

d.	NULL
d	NULL
=	NULL
o	NULL
r	NULL
r	NULL
r	NULL
t	NULL
t	NULL
|	NULL
=	NULL
o	NULL
T	NULL
J	NULL
T	NULL
00	NULL
4	NULL
2	NULL
B	NULL
4050607	NULL
o	NULL
4	NULL
r	NULL
:	NULL
4	NULL
50	NULL
607	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
3	NULL
.	NULL

Engagement	NULL
of	NULL
CD11b	NULL
and	NULL
CD11c	NULL
by	NULL
mAbs	NULL
or	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
rapidly	NULL
stimulates	NULL
secretion	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1B	NULL
on	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Human	NULL
monocytes	NULL
(	NULL
50	NULL
x	NULL
10°	NULL
cells/well	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
7	NULL
hours	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
following	NULL
antibodies	NULL
or	NULL
recombinant	NULL
fusion	NULL
proteins	NULL
:	NULL
isotype	NULL
control	NULL
IgG1	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
,	NULL
anti-CDi1a	NULL
(	NULL
clone	NULL
BU17	NULL
,	NULL
5	NULL
ug/ml	NULL
)	NULL
,	NULL
anti-CD11b	NULL
(	NULL
clone	NULL
ICRF44	NULL
,	NULL
20	NULL
g/mL	NULL
)	NULL
,	NULL
anti-CD11¢c	NULL
(	NULL
clone	NULL
BU15	NULL
,	NULL
5	NULL
g/mL	NULL
)	NULL
,	NULL
Z2-CD23	NULL
and	NULL
MBP-CD23	NULL
(	NULL
0.5	NULL
g/mL	NULL
)	NULL
,	NULL
and	NULL
ZZ-P	NULL
selectin	NULL
(	NULL
5	NULL
mg/mL	NULL
)	NULL
.	NULL

Secreted	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-18	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
were	NULL
detected	NULL
by	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
SE	NULL
values	NULL
(	NULL
n=	NULL
3	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
anti-CD11a	NULL
(	NULL
clone	NULL
G43-25B	NULL
)	NULL
,	NULL
anti-CD11b	NULL
(	NULL
clone	NULL
44	NULL
)	NULL
,	NULL
and	NULL
anti-CD11c	NULL
(	NULL
clone	NULL
3.9	NULL
)	NULL
mAbs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Monocytes	NULL
were	NULL
cultured	NULL
for	NULL
various	NULL
times	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
the	NULL
experiment	NULL
depicted	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

Then	NULL
,	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-16	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
by	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
SD	NULL
values	NULL
from	NULL
triplicate	NULL
performance	NULL
of	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
2	NULL
others	NULL
(	NULL
for	NULL
each	NULL
condition	NULL
,	NULL
SD	NULL
was	NULL
<	NULL
5	NULL
%	NULL
)	NULL
.	NULL

Ligation	NULL
of	NULL
CD11b	NULL
and	NULL
CD11c	NULL
B	NULL
,	NULL
integrins	NULL
triggers	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-186	NULL
release	NULL
on	NULL
human	NULL
monocytes	NULL
In	NULL
light	NULL
of	NULL
evidence	NULL
that	NULL
adhesion-dependent	NULL
signaling	NULL
can	NULL
,	NULL
under	NULL
some	NULL
circumstances	NULL
,	NULL
induce	NULL
mRNAs	NULL
without	NULL
synthesis	NULL
of	NULL
the	NULL
corresponding	NULL
proteins	NULL
by	NULL
monocytes	NULL
,	NULL
``	NULL
``	NULL
we	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
B	NULL
;	NULL
,	NULL
integrin	NULL
triggering	NULL
on	NULL
MIP-1a	NULL
«	NULL
and	NULL
secretion	NULL
in	NULL
our	NULL
system	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
constitutively	NULL
produced	NULL
low	NULL
levels	NULL
of	NULL
or	NULL
no	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1	NULL
.	NULL

However	NULL
,	NULL
after	NULL
stimulation	NULL
of	NULL
monocytes	NULL
by	NULL
anti-CD11b	NULL
mAbs	NULL
,	NULL
anti-CD11c	NULL
mAbs	NULL
,	NULL
MBP-CD23	NULL
,	NULL
or	NULL
ZZ-CD23	NULL
for	NULL
7	NULL
hours	NULL
,	NULL
release	NULL
of	NULL
high	NULL
amounts	NULL
of	NULL
MIP-la	NULL
«	NULL
in	NULL
culture	NULL
supernatants	NULL
was	NULL
observed	NULL
(	NULL
6.27	NULL
+	NULL
0.76	NULL
ng/mL	NULL
,	NULL
14.05	NULL
+	NULL
2.31	NULL
ng/mL	NULL
,	NULL
5.15	NULL
+	NULL
0.82	NULL
ng/mL	NULL
,	NULL
and	NULL
10.66	NULL
+	NULL
1.85	NULL
ng/mL	NULL
,	NULL
respectively	NULL
;	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
MIP-1B	NULL
secretion	NULL
was	NULL
also	NULL
markedly	NULL
stimulated	NULL
(	NULL
3.32	NULL
+	NULL
0.67	NULL
ng/mL	NULL
,	NULL
8.22	NULL
+	NULL
1.14	NULL
ng/mL	NULL
,	NULL
2.55	NULL
+	NULL
0.64	NULL
ng/mL	NULL
,	NULL
and	NULL
5.64	NULL
+	NULL
0.2	NULL
ng/mL	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
incubation	NULL
with	NULL
either	NULL
IgG1	NULL
isotype	NULL
control	NULL
mAb	NULL
,	NULL
anti-CD11a	NULL
mAbs	NULL
,	NULL
or	NULL
ZZ-P	NULL
selectin	NULL
fusion	NULL
protein	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
MIP-l	NULL
«	NULL
and	NULL
secretion	NULL
,	NULL
thereby	NULL
confirming	NULL
that	NULL
the	NULL
induction	NULL
was	NULL
not	NULL
due	NULL
to	NULL
nonspecific	NULL
activation	NULL
through	NULL
monocyte	NULL
Fc	NULL
receptors	NULL
or	NULL
mediated	NULL
by	NULL
the	NULL
ZZ	NULL
motif	NULL
of	NULL
CD23	NULL
fusion	NULL
proteins	NULL
.	NULL

Evaluation	NULL
of	NULL
the	NULL
time	NULL
course	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1	NULL
f	NULL
secretion	NULL
with	NULL
3	NULL
;	NULL
integrin	NULL
engagement	NULL
showed	NULL
that	NULL
both	NULL
chemokines	NULL
were	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
3	NULL
hours	NULL
after	NULL
stimulation	NULL
and	NULL
persisted	NULL
for	NULL
more	NULL
than	NULL
24	NULL
hours	NULL
(	NULL
Figure	NULL
3B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
data	NULL
were	NULL
consistent	NULL
B	NULL
»	NULL
INTEGRIN	NULL
LIGATION	NULL
CONTROLS	NULL
CHEMOKINE	NULL
SYNTHESIS	NULL
_	NULL
2935	NULL
with	NULL
the	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
MIP-l	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNAs	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Because	NULL
monocytes	NULL
are	NULL
highly	NULL
sensitive	NULL
to	NULL
endotoxin	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
effects	NULL
of	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
by	NULL
mAbs	NULL
or	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
on	NULL
chemokine	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
polymyxin	NULL
B	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Polymyxin	NULL
B	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-1f3	NULL
,	NULL
and	NULL
IL-8	NULL
mRNAs	NULL
induced	NULL
by	NULL
anti-CD11b	NULL
,	NULL
anti-CD11c	NULL
,	NULL
or	NULL
sCD23	NULL
chimeras	NULL
,	NULL
but	NULL
it	NULL
strongly	NULL
blocked	NULL
(	NULL
70	NULL
%	NULL
-80	NULL
%	NULL
inhibition	NULL
)	NULL
expression	NULL
of	NULL
the	NULL
chemokine	NULL
transcripts	NULL
induced	NULL
by	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
LPS	NULL
(	NULL
200	NULL
ng/mL	NULL
)	NULL
.	NULL

Engagement	NULL
of	NULL
CD11b	NULL
and	NULL
CD11¢	NULL
on	NULL
monocytes	NULL
by	NULL
mAbs	NULL
or	NULL
sCD23	NULL
was	NULL
previously	NULL
found	NULL
to	NULL
trigger	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
.	NULL

``	NULL
*+	NULL
``	NULL
``	NULL
*8	NULL
Moreover	NULL
,	NULL
TNF-a	NULL
is	NULL
known	NULL
to	NULL
stimulate	NULL
MIP-1	NULL
«	NULL
synthesis	NULL
.	NULL
``	NULL

To	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
chemokine	NULL
production	NULL
was	NULL
induced	NULL
by	NULL
(	NULL
B	NULL
;	NULL
integrin	NULL
triggering	NULL
resulting	NULL
from	NULL
autocrine	NULL
TNF-	NULL
production	NULL
,	NULL
we	NULL
did	NULL
experiments	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
the	NULL
TNF-u-blocking	NULL
agent	NULL
,	NULL
sTNFR-p55	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
sTNFR-p55	NULL
totally	NULL
blocked	NULL
MIP-l	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
expression	NULL
induced	NULL
by	NULL
soluble	NULL
TNF-a	NULL
,	NULL
but	NULL
it	NULL
did	NULL
not	NULL
affect	NULL
expression	NULL
induced	NULL
by	NULL
anti-CD11	NULL
mAbs	NULL
or	NULL
s€D23	NULL
fusion	NULL
proteins	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
CD11b	NULL
and	NULL
CD11¢	NULL
B	NULL
;	NULL
integrin	NULL
ligation	NULL
is	NULL
a	NULL
A	NULL
as	NULL
as	NULL
am	NULL
Eaa	NULL
ab	NULL
-	NULL
£88	NULL
SY	NULL
92	NULL
.Y	NULL
2	NULL
388	NULL
39	NULL
?	NULL

U	NULL
=	NULL
=	NULL
#	NULL
s	NULL
=	NULL
090	NULL
0	NULL
m==2==2	NULL
@	NULL
wn	NULL
o	NULL
m	NULL
m	NULL
E44	NULL
%	NULL
44	NULL
%	NULL
ENN	NULL
£383	NULL
polymyxin	NULL
B	NULL
\_	NULL
.	NULL

_	NULL
.	NULL

_	NULL
-p	NULL
g	NULL
oo	NULL
~-	NULL
cc	NULL
-~	NULL
#	NULL
MIP-1	NULL
$	NULL
-p	NULL
__	NULL
-	NULL
«	NULL
am	NULL
cas	NULL
MIP-1.0	NULL
.	NULL

[	NULL
iim	NULL
-	NULL
<	NULL
=	NULL
n	NULL
ma	NULL
ae	NULL
ass	NULL
c	NULL
am	NULL
-	NULL
CHa	NULL
Lepp	NULL
=	NULL
w	NULL
»	NULL
PM	NULL
GAPDH	NULL
-Jim	NULL
aw	NULL
sae	NULL
mae	NULL
cae	NULL
cae	NULL
eth	NULL
mae	NULL
ae	NULL
a	NULL
am	NULL
B	NULL
s	NULL
8	NULL
9	NULL
a	NULL
s	NULL
2	NULL
8	NULL
i	NULL
s	NULL
bsissssts	NULL
8998898898	NULL
gist	NULL
1	NULL
Eb—t—qﬁﬁﬁﬁdﬂtdiﬁ	NULL
sTNFR-P§5§5	NULL
--	NULL
4	NULL
-	NULL
-	NULL
-	NULL
--	NULL
+	NULL
4+	NULL
++	NULL
+	NULL
MIP	NULL
}	NULL
p	NULL
>	NULL
_	NULL
a	NULL
»	NULL
bd	NULL
b	NULL
MIP-10	NULL
-	NULL
#	NULL
»	NULL
_	NULL
«	NULL
»	NULL
~	NULL
>	NULL
cAPDHP	NULL
Figure	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
polymyxin	NULL
B	NULL
and	NULL
sTNFR-p55	NULL
on	NULL
induction	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNAs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nonadherent	NULL
human	NULL
monocytes	NULL
(	NULL
7	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
stimulated	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
37°C	NULL
with	NULL
either	NULL
anti-CDiib	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
,	NULL
anti-CD11c	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
200	NULL
ng/mL	NULL
)	NULL
,	NULL
ZZ-CD23	NULL
(	NULL
1	NULL
mg/mL	NULL
)	NULL
,	NULL
or	NULL
MBP-CD23	NULL
(	NULL
1	NULL
ug/mL	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
polymyxin	NULL
B	NULL
(	NULL
10	NULL
mg/mL	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Monocytes	NULL
(	NULL
7	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
cultured	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
37°C	NULL
with	NULL
anti-CD11a	NULL
(	NULL
5	NULL
ug/mL	NULL
)	NULL
,	NULL
anti-CD11b	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
,	NULL
anti-CD1ic	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
,	NULL
MBP-CD23	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
,	NULL
Z2-0D023	NULL
(	NULL
1	NULL
mg/mL	NULL
)	NULL
,	NULL
or	NULL
soluble	NULL
TNF-	NULL
«	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
sTNFR-p§55	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
RPA	NULL
for	NULL
expression	NULL
of	NULL
MIP-1	NULL
@	NULL
,	NULL
MIP-18	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
GAPDH	NULL
mRNAs	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
2	NULL
distinct	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2936	NULL
-	NULL
REZZONICO	NULL
etal	NULL
potent	NULL
way	NULL
to	NULL
activate	NULL
MIP-1a	NULL
and	NULL
MIP-1B	NULL
expression	NULL
on	NULL
human	NULL
monocytes	NULL
at	NULL
both	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
level	NULL
.	NULL

The	NULL
findings	NULL
also	NULL
show	NULL
that	NULL
this	NULL
chemokine	NULL
production	NULL
is	NULL
not	NULL
due	NULL
to	NULL
either	NULL
endotoxin	NULL
contamination	NULL
or	NULL
autocrine	NULL
TNF-a	NULL
production	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
and	NULL
degradation	NULL
of	NULL
IkB-a	NULL
in	NULL
monocytes	NULL
triggered	NULL
by	NULL
anti-CD11b	NULL
and	NULL
anti-CD11c	NULL
mAbs	NULL
or	NULL
sCD23	NULL
chimeras	NULL
To	NULL
gain	NULL
insight	NULL
into	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
elicits	NULL
induction	NULL
of	NULL
chemokines	NULL
in	NULL
monocytes	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
NFs	NULL
that	NULL
could	NULL
control	NULL
MIP-l	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
transcription	NULL
.	NULL

MIP-1	NULL
«	NULL
and	NULL
MIP-1	NULL
f	NULL
promoters	NULL
were	NULL
cloned	NULL
,	NULL
characterized	NULL
,	NULL
and	NULL
shown	NULL
to	NULL
contain	NULL
kB	NULL
response	NULL
elements	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
we	NULL
concentrated	NULL
on	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
with	NULL
B	NULL
;	NULL
integrin	NULL
triggering	NULL
on	NULL
human	NULL
monocytes	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

We	NULL
performed	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
on	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
anti-CD11b	NULL
mAbs	NULL
,	NULL
anti-CD11c	NULL
mAbs	NULL
,	NULL
or	NULL
sCD23	NULL
chimeric	NULL
proteins	NULL
.	NULL

Gel-shift	NULL
studies	NULL
using	NULL
a	NULL
consensus	NULL
target	NULL
sequence	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
revealed	NULL
a	NULL
constitutive	NULL
low	NULL
level	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
untreated	NULL
nonadherent	NULL
monocytes	NULL
that	NULL
was	NULL
not	NULL
altered	NULL
during	NULL
incubation	NULL
with	NULL
anti-CD11a	NULL
mAbs	NULL
or	NULL
ZZ-P	NULL
selectin	NULL
.	NULL

Interestingly	NULL
,	NULL
triggering	NULL
of	NULL
CD11b	NULL
or	NULL
CD11c	NULL
by	NULL
mAbs	NULL
or	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
NE-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
after	NULL
30	NULL
to	NULL
60	NULL
minutes	NULL
of	NULL
activation	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
4-7	NULL
,	NULL
and	NULL
Figure	NULL
5B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
induced	NULL
by	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
incubation	NULL
with	NULL
an	NULL
excess	NULL
(	NULL
50-100	NULL
fold	NULL
)	NULL
of	NULL
unlabeled	NULL
xB	NULL
oligonucleotide	NULL
prevented	NULL
ZZ-CD23-induced	NULL
binding	NULL
to	NULL
the	NULL
P-labeled	NULL
xB	NULL
probe	NULL
(	NULL
Figure	NULL
5B	NULL
,	NULL
lanes	NULL
5-6	NULL
)	NULL
,	NULL
whereas	NULL
incubation	NULL
with	NULL
an	NULL
NF-1	NULL
oligonucleotide	NULL
did	NULL
not	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
underlying	NULL
NF-KB	NULL
activation	NULL
is	NULL
known	NULL
.	NULL

It	NULL
involves	NULL
stimulus-induced	NULL
serine	NULL
phosphorylation	NULL
,	NULL
ubiquitination	NULL
,	NULL
and	NULL
subsequent	NULL
proteolysis	NULL
of	NULL
NF-KB	NULL
inhibitory	NULL
proteins	NULL
(	NULL
IxB	NULL
)	NULL
by	NULL
the	NULL
proteasome	NULL
complex	NULL
,	NULL
leading	NULL
to	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
.	NULL

``	NULL
*~	NULL
``	NULL
``	NULL
Thus	NULL
,	NULL
we	NULL
analyzed	NULL
expression	NULL
of	NULL
IxB-	NULL
«	NULL
protein	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
monocytes	NULL
after	NULL
B	NULL
;	NULL
integrin	NULL
ligation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6A	NULL
and	NULL
6B	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IkB-a	NULL
decreased	NULL
rapidly	NULL
after	NULL
15	NULL
and	NULL
30	NULL
minutes	NULL
of	NULL
activation	NULL
with	NULL
anti-CD11b	NULL
and	NULL
anti-CD1llc	NULL
mAbs	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
then	NULL
increased	NULL
again	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
IxB-	NULL
«	NULL
neosynthesis	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
MBP-CD23	NULL
chimera	NULL
induced	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
depletion	NULL
of	NULL
IxB-	NULL
«	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
IxB-a	NULL
down-regulation	NULL
appeared	NULL
more	NULL
sustained	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
ZZ-CD23	NULL
fusion	NULL
protein	NULL
,	NULL
probably	NULL
because	NULL
the	NULL
concentration	NULL
used	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
MBP-CD23	NULL
(	NULL
5	NULL
pg/mL	NULL
versus	NULL
1	NULL
pg/mL	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxB-a	NULL
remained	NULL
stable	NULL
after	NULL
30	NULL
minutes	NULL
of	NULL
stimulation	NULL
with	NULL
10	NULL
pg/mL	NULL
of	NULL
either	NULL
anti-CD11a	NULL
mAbs	NULL
or	NULL
ZZ-P	NULL
selectin	NULL
fusion	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
NF-kB	NULL
up-regulates	NULL
transcription	NULL
of	NULL
its	NULL
own	NULL
inhibitor	NULL
,	NULL
``	NULL
®	NULL
we	NULL
next	NULL
preincubated	NULL
monocytes	NULL
with	NULL
cycloheximide	NULL
to	NULL
prevent	NULL
new	NULL
IxB-a	NULL
«	NULL
synthesis	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
depletion	NULL
of	NULL
IxB-	NULL
«	NULL
induced	NULL
by	NULL
anti-CD11b	NULL
and	NULL
anti-CD1l1c	NULL
mAbs	NULL
or	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
was	NULL
more	NULL
pronounced	NULL
and	NULL
prolonged	NULL
.	NULL

Proteasome	NULL
inhibitors	NULL
prevent	NULL
NF-xB	NULL
activation	NULL
mediated	NULL
by	NULL
B2	NULL
integrin	NULL
ligation	NULL
Inhibitors	NULL
of	NULL
the	NULL
proteasome	NULL
complex	NULL
block	NULL
IB	NULL
degradation	NULL
and	NULL
are	NULL
therefore	NULL
potent	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
However	NULL
,	NULL
proteolysis-independent	NULL
pathways	NULL
for	NULL
NF-kB	NULL
activation	NULL
have	NULL
also	NULL
been	NULL
observed	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
2	NULL
proteasome	NULL
inhibi-tors	NULL
,	NULL
PSI	NULL
and	NULL
ALLN	NULL
,	NULL
would	NULL
affect	NULL
NF-KB	NULL
activation	NULL
induced	NULL
by	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
.	NULL

We	NULL
found	NULL
that	NULL
preincubation	NULL
of	NULL
monocytes	NULL
BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
A	NULL
£0	NULL
of	NULL
:	NULL
a	NULL
-	NULL
AB	NULL
-	NULL
A	NULL
0	NULL
9	NULL
0	NULL
Q0	NULL
90	NULL
g	NULL
€	NULL
E0	NULL
f	NULL
©	NULL
ind	NULL
<	NULL
4	NULL
<	NULL
I	NULL
8	NULL
r	NULL
--	NULL
O-1	NULL
0	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
30	NULL
60	NULL
30	NULL
60	NULL
30	NULL
60	NULL
a.	NULL
NF-xB	NULL
[	NULL
'	NULL
t	NULL
°	NULL
s	NULL
free	NULL
probe	NULL
bu	NULL
B	NULL
£	NULL
is	NULL
E	NULL
ZZ-CD23	NULL
a	NULL
4	NULL
TCC	NULL
1	NULL
§	NULL
9	NULL
3	NULL
5	NULL
¢	NULL
“	NULL
FNHF	NULL
'	NULL
E	NULL
c	NULL
E	NULL
s	NULL
N	NULL
o	NULL
so	NULL
100	NULL
mnjmldgzem	NULL
nese	NULL
[	NULL
|	NULL
~	NULL
t	NULL
o	NULL
Wp	NULL
=	NULL
(	NULL
W	NULL
free	NULL
probe	NULL
'	NULL
h	NULL
'	NULL
10	NULL
20	NULL
3	NULL
40	NULL
5	NULL
60	NULL
7	NULL
Figure	NULL
5	NULL
.	NULL

Engagement	NULL
of	NULL
B	NULL
;	NULL
integrins	NULL
at	NULL
the	NULL
monocyte	NULL
cell	NULL
surface	NULL
stimulates	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nonadherent	NULL
monocytes	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
30	NULL
and	NULL
60	NULL
minutes	NULL
with	NULL
anti-CD11a	NULL
(	NULL
BU17	NULL
,	NULL
5	NULL
pg/mL	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
anti-CD11b	NULL
(	NULL
ICRF44	NULL
,	NULL
5	NULL
mg/mL	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
anti-CD11c	NULL
(	NULL
BU15	NULL
,	NULL
5	NULL
pg/mL	NULL
;	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
)	NULL
mAbs	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
was	NULL
assessed	NULL
in	NULL
bandshift	NULL
experiments	NULL
.	NULL

Lane	NULL
8	NULL
shows	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
radiolabeled	NULL
kB	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nonadherent	NULL
monocytes	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
MBP-CD23	NULL
(	NULL
2	NULL
ug/mL	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
ZZ-P	NULL
selectin	NULL
(	NULL
5	NULL
pg/mL	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
ZZ-CD23	NULL
(	NULL
5	NULL
pg/mL	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
5	NULL
g	NULL
nuclear	NULL
extracts	NULL
in	NULL
bandshift	NULL
experiments	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
DNA-binding	NULL
complex	NULL
was	NULL
analyzed	NULL
by	NULL
incubation	NULL
with	NULL
a	NULL
50-	NULL
and	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
kB	NULL
probe	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
NF-1	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
under	NULL
the	NULL
conditions	NULL
depicted	NULL
in	NULL
lane	NULL
4	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
most	NULL
representative	NULL
of	NULL
4	NULL
distinct	NULL
experiments	NULL
.	NULL

with	NULL
PSI	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
208	NULL
proteasome	NULL
chymotrypsin-like	NULL
activity	NULL
,	NULL
abolished	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
induced	NULL
by	NULL
either	NULL
anti-CD11b	NULL
and	NULL
anti-CDlle	NULL
mAbs	NULL
or	NULL
s€D23	NULL
fusion	NULL
proteins	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
ALLN	NULL
significantly	NULL
inhibited	NULL
NF-KB	NULL
activation	NULL
by	NULL
anti-CD11b	NULL
and	NULL
anti-CD11c	NULL
mAbs	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
,	NULL
and	NULL
NF-kB	NULL
mobilization	NULL
mediated	NULL
by	NULL
sCD23	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
Figure	NULL
6	NULL
.	NULL

Ligation	NULL
of	NULL
B	NULL
;	NULL
integrins	NULL
induces	NULL
IB-	NULL
«	NULL
degradation	NULL
.	NULL

A	NULL
Nonadherent	NULL
monocytes	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
or	NULL
without	NULL
10	NULL
pg/mL	NULL
cycloheximide	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
various	NULL
times	NULL
B	NULL
»	NULL
INTEGRIN	NULL
LIGATION	NULL
CONTROLS	NULL
CHEMOKINE	NULL
SYNTHESIS	NULL
_	NULL
2937	NULL
B	NULL
-i-	NULL
Anti-CD11b	NULL
-	NULL
&	NULL
-	NULL
Anti-CD11b	NULL
+	NULL
CHX	NULL
-M-	NULL
Anti-CDi1c	NULL
-q-	NULL
Anti-CD11c	NULL
+	NULL
CHX	NULL
__	NULL
160	NULL
__	NULL
400	NULL
with	NULL
anti-CD11b	NULL
mAb	NULL
(	NULL
10	NULL
mg/mL	NULL
;	NULL
A	NULL
)	NULL
,	NULL
anti-CD11¢c	NULL
mAb	NULL
(	NULL
10	NULL
mg/mL	NULL
;	NULL
B	NULL
)	NULL
,	NULL
3	NULL
a	NULL
MBP-CD23	NULL
(	NULL
1	NULL
mg/mL	NULL
;	NULL
C	NULL
)	NULL
or	NULL
2Z-CD23	NULL
(	NULL
5	NULL
mg/mL	NULL
;	NULL
D	NULL
)	NULL
.	NULL

Whole-cell	NULL
=	NULL
1296	NULL
.l	NULL
~	NULL
``	NULL
son	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
50	NULL
mg	NULL
protein	NULL
was	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
$	NULL
$	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

IkB-	NULL
«	NULL
pro-	NULL
2	NULL
1	NULL
E.	NULL
teins	NULL
were	NULL
revealed	NULL
with	NULL
anti-lkB-	NULL
«	NULL
polyclonal	NULL
serum	NULL
followed	NULL
by	NULL
an	NULL
®	NULL
ike	NULL
i	NULL
200	NULL
ECL	NULL
reaction	NULL
.	NULL

Diagrams	NULL
represent	NULL
the	NULL
densitometric	NULL
scanning	NULL
of	NULL
o	NULL
o	NULL
IkB-a	NULL
protein	NULL
levels	NULL
in	NULL
each	NULL
Western	NULL
blot	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
g-	NULL
40	NULL
4	NULL
2	NULL
100	NULL
of	NULL
2	NULL
experiments	NULL
.	NULL

m	NULL
4	NULL
E	NULL
t	NULL
P3	NULL
~	NULL
0	NULL
T	NULL
T	NULL
T	NULL
F	NULL
0	NULL
T	NULL
T	NULL
T	NULL
0	NULL
20	NULL
40	NULL
so	NULL
so	NULL
o	NULL
20	NULL
40	NULL
eo	NULL
so	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Time	NULL
{	NULL
min	NULL
)	NULL
0	NULL
15	NULL
30	NULL
60	NULL
15	NULL
30	NULL
60	NULL
Time	NULL
{	NULL
min	NULL
)	NULL
0	NULL
15	NULL
30	NULL
60	NULL
15	NULL
30	NULL
60	NULL
CHX	NULL
-o-	NULL
<	NULL
-	NULL
-	NULL
4	NULL
#	NULL
+	NULL
#	NULL
CHX	NULL
<	NULL
=-	NULL
-	NULL
-	NULL
$	NULL
+4	NULL
+	NULL
#	NULL
IxB-o	NULL
p	NULL
atin	NULL
am	NULL
aa	NULL
»	NULL
aan	NULL
am	NULL
.	NULL

m	NULL
<	NULL
IcB-C	NULL
-R-	NULL
«	NULL
ip	NULL
h	NULL
foul	NULL
c	NULL
--	NULL
@	NULL
-	NULL
MBP-CD23	NULL
D	NULL
-O-	NULL
_	NULL
MBP-CD23	NULL
+	NULL
CHX	NULL
--	NULL
-	NULL
ZZ-CD23	NULL
5a	NULL
400	NULL
__	NULL
160	NULL
q	NULL
=	NULL
]	NULL
<	NULL
20	NULL
-	NULL
300	NULL
z	NULL
120	NULL
4	NULL
0	NULL
@	NULL
$	NULL
$	NULL
é	NULL
200	NULL
A	NULL
;	NULL
a0	NULL
4	NULL
B	NULL
B	NULL
g-	NULL
100	NULL
$	NULL
-	NULL
40	NULL
4	NULL
$	NULL
3	NULL
*~	NULL
0	NULL
~	NULL
0	NULL
T	NULL
T	NULL
T	NULL
o	NULL
20	NULL
40	NULL
60	NULL
80	NULL
a	NULL
20	NULL
40	NULL
so	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
15	NULL
30	NULL
60	NULL
15	NULL
30	NULL
60	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
15	NULL
30	NULL
6	NULL
CHX	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
CHX	NULL
-	NULL
-	NULL
-	NULL
IxB-o-pp	NULL
>	NULL
e	NULL
(	NULL
8	NULL
UB	NULL
[	NULL
c	NULL
``	NULL
a	NULL
chimeras	NULL
was	NULL
markedly	NULL
suppressed	NULL
by	NULL
the	NULL
maximal	NULL
dose	NULL
of	NULL
ALLN	NULL
(	NULL
100	NULL
pM	NULL
;	NULL
Figure	NULL
7C	NULL
)	NULL
.	NULL

activation	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
CD11b	NULL
and	NULL
CD11c	NULL
signaling	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
expression	NULL
in	NULL
monocytes	NULL
To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
controlling	NULL
MIP-1a	NULL
and	NULL
MIP-1	NULL
f	NULL
up-regulation	NULL
induced	NULL
by	NULL
CD11b	NULL
or	NULL
CD11¢	NULL
triggering	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
effects	NULL
of	NULL
proteasome	NULL
inhibitors	NULL
on	NULL
expression	NULL
of	NULL
chemokine	NULL
transcripts	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
monocytes	NULL
with	NULL
40	NULL
uM	NULL
PSI	NULL
abrogated	NULL
or	NULL
strongly	NULL
decreased	NULL
expression	NULL
of	NULL
MIP-la	NULL
and	NULL
MIP-1f	NULL
induced	NULL
by	NULL
anti-CD11b	NULL
and	NULL
anti-CD11lc	NULL
mAbs	NULL
or	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
(	NULL
Figure	NULL
8A	NULL
,	NULL
8C	NULL
,	NULL
and	NULL
8D	NULL
)	NULL
.	NULL

At	NULL
the	NULL
highest	NULL
concentration	NULL
used	NULL
(	NULL
100	NULL
M	NULL
)	NULL
,	NULL
ALLN	NULL
markedly	NULL
inhibited	NULL
MIP-la	NULL
and	NULL
MIP-1fB	NULL
gene	NULL
expression	NULL
on	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
(	NULL
Figure	NULL
8B	NULL
,	NULL
8C	NULL
,	NULL
and	NULL
8D	NULL
)	NULL
.	NULL

Both	NULL
PSI	NULL
and	NULL
ALLN	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
effective	NULL
in	NULL
blocking	NULL
induction	NULL
of	NULL
steady-state	NULL
mRNA	NULL
levels	NULL
of	NULL
MIP-1f	NULL
than	NULL
those	NULL
of	NULL
MIP-1	NULL
«	NULL
.	NULL

The	NULL
constitutive	NULL
level	NULL
of	NULL
GAPDH	NULL
mRNA	NULL
was	NULL
not	NULL
altered	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

Interestingly	NULL
,	NULL
IL-8	NULL
mRNA	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
PSI	NULL
or	NULL
ALLN	NULL
;	NULL
instead	NULL
,	NULL
it	NULL
tended	NULL
to	NULL
be	NULL
potentiated	NULL
by	NULL
them	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
activation	NULL
of	NULL
NF-KB	NULL
is	NULL
mandatory	NULL
for	NULL
up-regulation	NULL
of	NULL
MIP-1B	NULL
gene	NULL
expression	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
MIP-la	NULL
gene	NULL
expression	NULL
with	NULL
CD11b	NULL
and	NULL
CD11c	NULL
3	NULL
;	NULL
integrin	NULL
engagement	NULL
.	NULL

Discussion	NULL
Numerous	NULL
proinflammatory	NULL
and	NULL
anti-inflammatory	NULL
genes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
genes	NULL
not	NULL
known	NULL
to	NULL
be	NULL
related	NULL
to	NULL
immunity	NULL
,	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
regulated	NULL
in	NULL
response	NULL
to	NULL
engagement	NULL
of	NULL
integrins	NULL
.	NULL

Growing	NULL
evidence	NULL
supports	NULL
the	NULL
idea	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
their	NULL
crucial	NULL
function	NULL
in	NULL
cell-adhesion	NULL
reactions	NULL
during	NULL
immune-inflammatory	NULL
mechanisms	NULL
,	NULL
B	NULL
;	NULL
integrins	NULL
also	NULL
generate	NULL
outside-in	NULL
cellular	NULL
signaling	NULL
that	NULL
leads	NULL
to	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
demonstrated	NULL
previously	NULL
that	NULL
triggering	NULL
of	NULL
CD11b	NULL
or	NULL
CD11¢c	NULL
a	NULL
chains	NULL
of	NULL
B	NULL
;	NULL
integrins	NULL
by	NULL
mAbs	NULL
or	NULL
chimeric	NULL
sCD23	NULL
on	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
rapidly	NULL
activates	NULL
signaling	NULL
pathways	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
1	NULL
and	NULL
2	NULL
and	NULL
p38-stress-activated	NULL
protein	NULL
kinase	NULL
2	NULL
that	NULL
cooperate	NULL
in	NULL
controlling	NULL
IL-1	NULL
B	NULL
production	NULL
.	NULL
``	NULL

''	NULL
Our	NULL
current	NULL
results	NULL
provide	NULL
new	NULL
evidence	NULL
that	NULL
CD11b	NULL
and	NULL
CD11c	NULL
engagement	NULL
can	NULL
also	NULL
have	NULL
a	NULL
profound	NULL
effect	NULL
on	NULL
chemokine	NULL
release	NULL
and	NULL
consequently	NULL
on	NULL
recruitment	NULL
of	NULL
inflammatory	NULL
cells	NULL
during	NULL
initiation	NULL
of	NULL
an	NULL
inflammatory	NULL
response	NULL
.	NULL

Many	NULL
studies	NULL
have	NULL
established	NULL
that	NULL
chemokines	NULL
not	NULL
only	NULL
induce	NULL
leukocyte	NULL
migration	NULL
but	NULL
that	NULL
they	NULL
also	NULL
facilitate	NULL
leukocyte	NULL
adhesion	NULL
,	NULL
particularly	NULL
through	NULL
their	NULL
stimulatory	NULL
effect	NULL
on	NULL
cell-surface	NULL
expression	NULL
and	NULL
avidity	NULL
of	NULL
both	NULL
CD11b	NULL
and	NULL
CD11¢	NULL
but	NULL
not	NULL
CD11a.126263	NULL
Conversely	NULL
,	NULL
interaction	NULL
of	NULL
monocytes	NULL
with	NULL
endothelial	NULL
cells	NULL
,	NULL
plate-lets	NULL
,	NULL
or	NULL
fibroblasts	NULL
was	NULL
reported	NULL
to	NULL
increase	NULL
production	NULL
of	NULL
chemokines	NULL
,	NULL
particularly	NULL
MIP-1	NULL
«	NULL
.	NULL

``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
However	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
adhesion	NULL
molecules	NULL
expressed	NULL
on	NULL
monocytes	NULL
and	NULL
responsible	NULL
for	NULL
contact-induced	NULL
chemokine	NULL
secretion	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

In	NULL
the	NULL
current	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
direct	NULL
triggering	NULL
of	NULL
CD11b	NULL
and	NULL
CD11¢	NULL
but	NULL
not	NULL
CD11a	NULL
a	NULL
chains	NULL
of	NULL
;	NULL
integrins	NULL
on	NULL
primary	NULL
human	NULL
monocytes	NULL
stimulated	NULL
synthesis	NULL
of	NULL
IL-8	NULL
,	NULL
MIP-1a	NULL
,	NULL
and	NULL
MIP-1f	NULL
.	NULL

IL-8	NULL
production	NULL
was	NULL
previously	NULL
reported	NULL
to	NULL
be	NULL
enhanced	NULL
through	NULL
B	NULL
;	NULL
integrin	NULL
aggregation	NULL
on	NULL
human	NULL
polymorphonuclear	NULL
neutrophils	NULL
.	NULL
``	NULL

The	NULL
current	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
show	NULL
that	NULL
ligation	NULL
of	NULL
CD11b	NULL
or	NULL
CD11c	NULL
by	NULL
mAbs	NULL
up-regulates	NULL
MIP-l	NULL
«	NULL
and	NULL
MIP-18B	NULL
expression	NULL
and	NULL
secretion	NULL
on	NULL
primary	NULL
human	NULL
monocytes	NULL
.	NULL

Our	NULL
findings	NULL
also	NULL
indicate	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1B	NULL
production	NULL
by	NULL
anti-CD11b	NULL
and	NULL
anti-CD11¢	NULL
mAbs	NULL
is	NULL
physiologi-cally	NULL
relevant	NULL
,	NULL
since	NULL
such	NULL
stimulation	NULL
can	NULL
also	NULL
be	NULL
produced	NULL
by	NULL
the	NULL
natural	NULL
ligand	NULL
of	NULL
these	NULL
integrins	NULL
,	NULL
s€D23	NULL
.	NULL

The	NULL
induction	NULL
probably	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2938	NULL
REZZONICO	NULL
et	NULL
al	NULL
A	NULL
72	NULL
bid	NULL
o	NULL
ee	NULL
$	NULL
3	NULL
0	NULL
$	NULL
0	NULL
9	NULL
d.	NULL
4	NULL
4	NULL
N	NULL
=s	NULL
I	NULL
|	NULL
MJ	NULL
11	NULL
1	NULL
1	NULL
1	NULL
PSI	NULL
-	NULL
o-	NULL
$	NULL
0	NULL
-	NULL
$	NULL
0	NULL
-	NULL
#	NULL
o-	NULL
-	NULL
+	NULL
seee	NULL
[	NULL
|	NULL
#	NULL
(	NULL
D	NULL
one	NULL
(	NULL
igh	NULL
tout	NULL
th	NULL
~	NULL
ul	NULL
10	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
B	NULL
Anti-CD11b	NULL
Anti-CD11c	NULL
U	NULL
1	NULL
1	NULL
I	NULL
ALLN	NULL
(	NULL
_M	NULL
)	NULL
o	NULL
o	NULL
2	NULL
20	NULL
100	NULL
_	NULL
o	NULL
0	NULL
2	NULL
20	NULL
100	NULL
``	NULL
l	NULL
_	NULL
e	NULL
L	NULL
S	NULL
1°	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
C	NULL
ZZ-CD23	NULL
MBP-CD23	NULL
mm-	NULL
``	NULL
``	NULL
7	NULL
mm~-71	NULL
ALLN	NULL
|-	NULL
o-	NULL
-	NULL
+	NULL
#	NULL
NF-KBI	NULL
:	NULL
at	NULL
“	NULL
'	NULL
W	NULL
w	NULL
1°	NULL
203	NULL
4	NULL
50	NULL
6	NULL
Figure	NULL
7	NULL
.	NULL

Effect	NULL
of	NULL
proteasome	NULL
inhibitors	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
induced	NULL
by	NULL
B	NULL
;	NULL
integrin	NULL
triggering	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nonadherent	NULL
monocytes	NULL
(	NULL
10-15	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
not	NULL
preincubated	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
9	NULL
)	NULL
or	NULL
were	NULL
preincubated	NULL
with	NULL
100	NULL
uM	NULL
PSI	NULL
for	NULL
1	NULL
hour	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
8	NULL
)	NULL
,	NULL
anti-CD11b	NULL
mAb	NULL
(	NULL
10	NULL
mg/mL	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
anti-CD11c	NULL
mAb	NULL
(	NULL
10	NULL
pg/mL	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
Z2-CD23	NULL
(	NULL
5	NULL
mg/mL	NULL
;	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
MBP-CD23	NULL
(	NULL
2	NULL
g/mL	NULL
;	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nonadherent	NULL
monocytes	NULL
were	NULL
pretreated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
ALLN	NULL
(	NULL
2	NULL
,	NULL
20	NULL
,	NULL
and	NULL
100	NULL
mM	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
(	NULL
lanes	NULL
3-5	NULL
and	NULL
8-10	NULL
)	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
mAbs	NULL
to	NULL
CD11b	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
or	NULL
CD11c	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nonadherent	NULL
monocytes	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
without	NULL
ALLN	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
)	NULL
or	NULL
with	NULL
100	NULL
uM	NULL
ALLN	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
before	NULL
stimulation	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
Z2-CD23	NULL
(	NULL
5	NULL
ug/mL	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
MBP-CD23	NULL
(	NULL
2	NULL
g/mL	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
medium	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
bandshift	NULL
experiments	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
3	NULL
similar	NULL
experiments	NULL
.	NULL

takes	NULL
place	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
according	NULL
to	NULL
the	NULL
rapid	NULL
time	NULL
course	NULL
of	NULL
induction	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1B	NULL
mRNA	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
chemokine	NULL
production	NULL
induced	NULL
by	NULL
CD11b	NULL
or	NULL
CD11¢	NULL
ligation	NULL
was	NULL
selective	NULL
for	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-1f3	NULL
,	NULL
and	NULL
IL-8	NULL
,	NULL
since	NULL
it	NULL
did	NULL
not	NULL
take	NULL
place	NULL
on	NULL
several	NULL
other	NULL
CC	NULL
or	NULL
CXC	NULL
chemokines	NULL
,	NULL
including	NULL
MCP-1	NULL
,	NULL
RANTES	NULL
,	NULL
and	NULL
IP-10	NULL
.	NULL

As	NULL
in	NULL
our	NULL
study	NULL
of	NULL
IL-1	NULL
}	NULL
production	NULL
,	NULL
``	NULL
we	NULL
can	NULL
here	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
endotoxin	NULL
contamination	NULL
contributed	NULL
to	NULL
activation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
MIPs	NULL
,	NULL
since	NULL
addition	NULL
of	NULL
polymyxin	NULL
B	NULL
sulfate	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
and	NULL
neutralizes	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
stimulatory	NULL
activities	NULL
of	NULL
anti-CD11b	NULL
and	NULL
anti-CD11c	NULL
mAbs	NULL
or	NULL
s€D23	NULL
fusion	NULL
proteins	NULL
but	NULL
did	NULL
markedly	NULL
block	NULL
the	NULL
effect	NULL
of	NULL
200	NULL
ng/mL	NULL
LPS	NULL
.	NULL

Proinflammatory	NULL
cytokines	NULL
,	NULL
particularly	NULL
IL-1	NULL
and	NULL
TNF-	NULL
«	NULL
,	NULL
are	NULL
potent	NULL
inducers	NULL
of	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
MIP-la	NULL
«	NULL
production	NULL
on	NULL
several	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
alveolar	NULL
macrophages	NULL
,	NULL
inflammatory	NULL
fibroblasts	NULL
,	NULL
and	NULL
osteosarcoma	NULL
cells	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
we	NULL
and	NULL
found	NULL
that	NULL
engagement	NULL
of	NULL
B	NULL
;	NULL
integrins	NULL
by	NULL
different	NULL
methods	NULL
,	NULL
including	NULL
binding	NULL
to	NULL
specific	NULL
mAbs	NULL
,	NULL
adherence	NULL
to	NULL
surface	NULL
coated	NULL
with	NULL
fibrinogen	NULL
,	NULL
incubation	NULL
with	NULL
s€D23	NULL
,	NULL
and	NULL
direct	NULL
contact	NULL
with	NULL
T	NULL
cells	NULL
,	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IL-1	NULL
and	NULL
TNF-	NULL
«	NULL
on	NULL
monocytes	NULL
.	NULL

However	NULL
,	NULL
using	NULL
sTNFR	NULL
or	NULL
IL-1Ra	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
,	NULL
in	NULL
our	NULL
system	NULL
,	NULL
expression	NULL
of	NULL
MIP-1a	NULL
,	NULL
MIP-16	NULL
%	NULL
,	NULL
and	NULL
BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
IL-8	NULL
induced	NULL
by	NULL
engagement	NULL
of	NULL
CD11b	NULL
or	NULL
CD11¢	NULL
was	NULL
not	NULL
mediated	NULL
by	NULL
prior	NULL
secretion	NULL
of	NULL
TNF-a	NULL
or	NULL
IL-1	NULL
B	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
induction	NULL
of	NULL
genes	NULL
expressing	NULL
inflammatory	NULL
mediators	NULL
such	NULL
as	NULL
adhesion	NULL
molecules	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
chemokines	NULL
is	NULL
regulated	NULL
partly	NULL
by	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB-Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Furthermore	NULL
,	NULL
NF-kB	NULL
was	NULL
reported	NULL
to	NULL
control	NULL
transcription	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
IL-8.5	NULL
>	NULL
``	NULL
Thus	NULL
,	NULL
the	NULL
aim	NULL
of	NULL
our	NULL
study	NULL
was	NULL
to	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
control	NULL
of	NULL
MIP-1a	NULL
«	NULL
,	NULL
MIP-1f3	NULL
,	NULL
and	NULL
IL-8	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
ligation	NULL
of	NULL
3	NULL
;	NULL
integrins	NULL
on	NULL
primary	NULL
human	NULL
monocytes	NULL
.	NULL

We	NULL
demonstrated	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
specific	NULL
engagement	NULL
by	NULL
mAbs	NULL
of	NULL
CD11b	NULL
or	NULL
CD11¢	NULL
but	NULL
not	NULL
CD11a	NULL
on	NULL
nonadherent	NULL
human	NULL
monocytes	NULL
induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
showing	NULL
that	NULL
fibrinogen	NULL
activates	NULL
NE-	NULL
«	NULL
B	NULL
transcription	NULL
by	NULL
signaling	NULL
through	NULL
CD11b-CD18	NULL
in	NULL
U937	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
.	NULL
``	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
our	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
show	NULL
that	NULL
stimulation	NULL
of	NULL
human	NULL
monocytes	NULL
by	NULL
sCD23	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
using	NULL
the	NULL
proteasome-specific	NULL
inhibitors	NULL
PSI	NULL
and	NULL
ALLN	NULL
to	NULL
block	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
we	NULL
found	NULL
new	NULL
evidence	NULL
of	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
control	NULL
of	NULL
MIP-1B	NULL
expression	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
MIP-1	NULL
«	NULL
expression	NULL
induced	NULL
by	NULL
ligation	NULL
of	NULL
CD11b	NULL
or	NULL
CD11c	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
agents	NULL
slightly	NULL
potentiated	NULL
IL-8	NULL
steady-state	NULL
mRNA	NULL
induced	NULL
by	NULL
B	NULL
;	NULL
integrin	NULL
engagement	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
previous	NULL
investigation	NULL
showing	NULL
that	NULL
PSI	NULL
inhibits	NULL
LPS-induced	NULL
IL-8	NULL
gene	NULL
A	NULL
#	NULL
8	NULL
$	NULL
:8¢	NULL
B	NULL
£566	NULL
5	NULL
5	NULL
6	NULL
6	NULL
39999	NULL
99	NULL
E	NULL
E	NULL
E	NULL
E	NULL
E	NULL
E	NULL
E	NULL
Anti-CD11b	NULL
_	NULL
Anti-CD11c	NULL
PSI	NULL
--	NULL
-	NULL
-++	NULL
+	NULL
ALLN	NULL
(	NULL
pM	NULL
)	NULL
0	NULL
0	NULL
2	NULL
20100	NULL
0	NULL
0	NULL
220100	NULL
IP	NULL
AP	NULL
Ie	NULL
wat	NULL
p	NULL
>	NULL
-	NULL
-	NULL
_	NULL
MIP-1	NULL
o	NULL
gi	NULL
»	NULL
coun	NULL
lls	NULL
=	NULL
-	NULL
MIP-10	NULL
#	NULL
»	NULL
n	NULL
le	NULL
i	NULL
»	NULL
~	NULL
=	NULL
\-	NULL
:	NULL
-	NULL
-	NULL
le	NULL
care	NULL
otal	NULL
G	NULL
AP	NULL
DH	NULL
-Jim	NULL
tit	NULL
m	NULL
ii	NULL
mas	NULL
ome	NULL
aas	NULL
GAPDH	NULL
<	NULL
p	NULL
«	NULL
n	NULL
san	NULL
m	NULL
oman	NULL
.	NULL

Wineries	NULL
&	NULL
g	NULL
c	NULL
22-CD23	NULL
D	NULL
g	NULL
B	NULL
C	NULL
g	NULL
§	NULL
_3	NULL
29	NULL
.	NULL

{	NULL
$	NULL
93	NULL
§	NULL
al	NULL
$	NULL
67	NULL
8	NULL
a	NULL
<	NULL
4	NULL
E	NULL
=	NULL
L	NULL
g	NULL
2	NULL
7	NULL
E0	NULL
1+	NULL
+	NULL
-	NULL
an	NULL
MIP-1f	NULL
p	NULL
>	NULL
-	NULL
@	NULL
m	NULL
»	NULL
P	NULL
MIP-1	NULL
a	NULL
Jie	NULL
=	NULL
-	NULL
dit	NULL
s	NULL
MIP-1	NULL
o	NULL
:	NULL
Jip	NULL
-	NULL
@	NULL
@	NULL
-s	NULL
»	NULL
GAPDH	NULL
-	NULL
»	NULL
»	NULL
Figure	NULL
8	NULL
.	NULL

Effect	NULL
of	NULL
proteasome	NULL
inhibitors	NULL
on	NULL
steady-state	NULL
levels	NULL
of	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-1B	NULL
,	NULL
and	NULL
IL-8	NULL
mRNAs	NULL
induced	NULL
by	NULL
anti-CD11b/c	NULL
mAbs	NULL
or	NULL
sCD23	NULL
fusion	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nonadherent	NULL
monocytes	NULL
(	NULL
7	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
not	NULL
preincubated	NULL
or	NULL
were	NULL
preincubated	NULL
with	NULL
40	NULL
wM	NULL
PSI	NULL
for	NULL
1	NULL
hour	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
anti-CD11a	NULL
(	NULL
5	NULL
mg/mL	NULL
)	NULL
,	NULL
anti-CD11b	NULL
(	NULL
5	NULL
mg/mL	NULL
)	NULL
,	NULL
or	NULL
anti-CD1ic	NULL
(	NULL
5	NULL
g/mL	NULL
)	NULL
mAbs	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
were	NULL
pretreated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
ALLN	NULL
(	NULL
2	NULL
,	NULL
20	NULL
,	NULL
and	NULL
100	NULL
mM	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
anti-CD11b	NULL
(	NULL
5	NULL
g/mL	NULL
)	NULL
or	NULL
anti-CD11c	NULL
(	NULL
5	NULL
ug/mL	NULL
)	NULL
mAbs	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

(	NULL
C	NULL
,	NULL
D	NULL
)	NULL
Monocytes	NULL
were	NULL
not	NULL
preincubated	NULL
or	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
hour	NULL
with	NULL
40	NULL
M	NULL
PSI	NULL
or	NULL
100	NULL
M	NULL
ALLN	NULL
before	NULL
stimulation	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
22-CD23	NULL
(	NULL
2	NULL
g/mL	NULL
)	NULL
,	NULL
MBP-CD23	NULL
(	NULL
1	NULL
mg/mL	NULL
)	NULL
,	NULL
or	NULL
medium	NULL
alone	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
RPA	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
3	NULL
similar	NULL
experiments	NULL
.	NULL

>	NULL
e	NULL
-	NULL
wilh	NULL
GAPDH	NULL
[	NULL
i-	NULL
#	NULL
#	NULL
-	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
transcription	NULL
while	NULL
increasing	NULL
mRNA	NULL
stability	NULL
,	NULL
thereby	NULL
producing	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
IL-8	NULL
production	NULL
.	NULL
``	NULL

''	NULL
Chemokines	NULL
have	NULL
been	NULL
found	NULL
in	NULL
tissues	NULL
in	NULL
several	NULL
pathologic	NULL
conditions	NULL
characterized	NULL
by	NULL
distinct	NULL
leukocytic	NULL
infiltrates	NULL
,	NULL
including	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
sepsis	NULL
,	NULL
atherosclerosis	NULL
,	NULL
asthma	NULL
,	NULL
psoriasis	NULL
,	NULL
ischemia-reperfusion	NULL
injury	NULL
,	NULL
and	NULL
many	NULL
pulmonary	NULL
disorders	NULL
.	NULL

!	NULL
``	NULL

MIP-1a	NULL
and	NULL
MIP-1f	NULL
are	NULL
particularly	NULL
elevated	NULL
in	NULL
synovial	NULL
fluids	NULL
of	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
osteoarthritis	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
may	NULL
consequently	NULL
play	NULL
a	NULL
role	NULL
in	NULL
recruiting	NULL
monocytes	NULL
to	NULL
inflamed	NULL
joints	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Furthermore	NULL
,	NULL
MIP-1	NULL
«	NULL
is	NULL
produced	NULL
by	NULL
osteo-blasts	NULL
and	NULL
stimulates	NULL
the	NULL
motility	NULL
of	NULL
osteoclasts	NULL
,	NULL
which	NULL
could	NULL
in	NULL
turn	NULL
modulate	NULL
bone	NULL
resorption	NULL
in	NULL
inflammatory	NULL
disorders	NULL
.	NULL

``	NULL
>	NULL
``	NULL
*	NULL
On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
s€D23	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
serum	NULL
and	NULL
synovial	NULL
fluids	NULL
of	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
associated	NULL
with	NULL
worsening	NULL
of	NULL
the	NULL
disease	NULL
.	NULL
``	NULL

''	NULL
Synovial	NULL
macrophages	NULL
also	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
CD23	NULL
and	NULL
its	NULL
counter-ligands	NULL
CD11b	NULL
and	NULL
These	NULL
data	NULL
suggest	NULL
that	NULL
an	NULL
interaction	NULL
of	NULL
sCD23	NULL
or	NULL
CD23	NULL
expressed	NULL
on	NULL
macrophages	NULL
with	NULL
CD11b	NULL
or	NULL
CD11¢	NULL
could	NULL
play	NULL
a	NULL
major	NULL
part	NULL
in	NULL
production	NULL
of	NULL
MIP-1	NULL
«	NULL
and	NULL
MIP-1	NULL
f	NULL
in	NULL
the	NULL
joint	NULL
and	NULL
may	NULL
therefore	NULL
constitute	NULL
an	NULL
important	NULL
mechanism	NULL
sustaining	NULL
continuous	NULL
recruitment	NULL
of	NULL
inflammatory	NULL
cells	NULL
and	NULL
maintaining	NULL
chronic	NULL
inflammation	NULL
.	NULL

Thus	NULL
,	NULL
further	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
control	NULL
production	NULL
of	NULL
chemokines	NULL
induced	NULL
by	NULL
f	NULL
;	NULL
integrin	NULL
B	NULL
»	NULL
INTEGRIN	NULL
LIGATION	NULL
CONTROLS	NULL
CHEMOKINE	NULL
SYNTHESIS	NULL
-	NULL
2939	NULL
engagement	NULL
may	NULL
lay	NULL
the	NULL
foundation	NULL
for	NULL
new	NULL
anti-inflammatory	NULL
treatments	NULL
.	NULL

Two	NULL
major	NULL
strategies	NULL
for	NULL
inhibiting	NULL
chemokine	NULL
activity	NULL
to	NULL
limit	NULL
leukocyte	NULL
migration	NULL
in	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
have	NULL
been	NULL
proposed-one	NULL
involving	NULL
the	NULL
use	NULL
of	NULL
antiligand	NULL
and	NULL
the	NULL
other	NULL
the	NULL
use	NULL
of	NULL
antireceptor	NULL
.	NULL
``	NULL

''	NULL
An	NULL
alternative	NULL
approach	NULL
,	NULL
blockage	NULL
of	NULL
leukocyte-adhesion	NULL
mechanisms	NULL
,	NULL
is	NULL
also	NULL
being	NULL
tested	NULL
in	NULL
Chemokine	NULL
activities	NULL
could	NULL
also	NULL
be	NULL
modulated	NULL
by	NULL
interfering	NULL
in	NULL
signal-transduction	NULL
pathways	NULL
,	NULL
eg	NULL
,	NULL
by	NULL
blocking	NULL
NF-kB	NULL
by	NULL
adenoviral	NULL
infection	NULL
with	NULL
IkB-o.8¢88	NULL
In	NULL
conclusion	NULL
,	NULL
this	NULL
study	NULL
identified	NULL
a	NULL
novel	NULL
link	NULL
between	NULL
CD11b	NULL
and	NULL
CD11c	NULL
B	NULL
;	NULL
integrins	NULL
and	NULL
expression	NULL
of	NULL
MIP-l	NULL
«	NULL
and	NULL
MIP-1f	NULL
chemokines	NULL
in	NULL
monocytes	NULL
.	NULL

The	NULL
results	NULL
extend	NULL
previous	NULL
findings	NULL
on	NULL
the	NULL
important	NULL
role	NULL
of	NULL
these	NULL
adhesion	NULL
molecules	NULL
in	NULL
regulating	NULL
host	NULL
immune	NULL
defense	NULL
mechanisms	NULL
and	NULL
inflammatory	NULL
processes	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr	NULL
M.	NULL
Bird	NULL
for	NULL
kindly	NULL
providing	NULL
ZZ-CD23	NULL
,	NULL
MBP-CD23	NULL
,	NULL
and	NULL
ZZ-selectin	NULL
fusion	NULL
proteins	NULL
,	NULL
M.T	NULL
.	NULL

Kauffmann	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
R.	NULL
Rehm	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
.	NULL

Taub	NULL
DD	NULL
.	NULL

Chemokine-leukocyte	NULL
interactions	NULL
.	NULL

Cy-	NULL
tokine	NULL
Growth	NULL
Factor	NULL
Rev	NULL
.	NULL

1996	NULL
;	NULL
7:355-376	NULL
.	NULL

Springer	NULL
TA	NULL
.	NULL

Characterization	NULL
of	NULL
ICAM-2	NULL
and	NULL
evidence	NULL
for	NULL
a	NULL
third	NULL
counter-receptor	NULL
for	NULL
LFA-1	NULL
.	NULL

J	NULL
leukocyte	NULL
integrin	NULL
Mac-1	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
.	NULL

1995	NULL
;	NULL
130:1473-1482	NULL
.	NULL

2	NULL
.	NULL

Baggiolin	NULL
M	NULL
,	NULL
Dewald	NULL
B	NULL
,	NULL
Moser	NULL
B	NULL
.	NULL

Human	NULL
chemo-	NULL
Exp	NULL
Med	NULL
.	NULL

1991	NULL
;	NULL
174:253-267	NULL
.	NULL

26	NULL
.	NULL

Stacker	NULL
SA	NULL
,	NULL
Springer	NULL
TA	NULL
.	NULL

Leukocyte	NULL
integrin	NULL
kines	NULL
:	NULL
an	NULL
update	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
.	NULL

1997	NULL
;	NULL
15	NULL
:	NULL
16	NULL
.	NULL

Fawcett	NULL
J	NULL
,	NULL
Holiness	NULL
CLL	NULL
,	NULL
Needham	NULL
LA	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Mo-	NULL
p150,95	NULL
(	NULL
CD11¢/CD18	NULL
)	NULL
functions	NULL
as	NULL
an	NULL
adhesion	NULL
675-705.	NULL
lecular	NULL
cloning	NULL
of	NULL
ICAM-3	NULL
,	NULL
a	NULL
third	NULL
ligand	NULL
for	NULL
molecule	NULL
binding	NULL
to	NULL
a	NULL
counter-receptor	NULL
on	NULL
stimu-	NULL
3	NULL
.	NULL

Baggiolin	NULL
M.	NULL
Chemokines	NULL
and	NULL
leukocyte	NULL
traffic	NULL
.	NULL

LFA-1	NULL
,	NULL
constitutively	NULL
expressed	NULL
on	NULL
resting	NULL
leuko-	NULL
lated	NULL
endothelium	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1991	NULL
;	NULL
146:648-Nature	NULL
.	NULL

1998	NULL
;	NULL
392:565-568.	NULL
cytes	NULL
.	NULL

Nature	NULL
.	NULL

1992	NULL
;	NULL
360:481-484	NULL
.	NULL

655	NULL
.	NULL

4	NULL
.	NULL

Vaddi	NULL
K	NULL
,	NULL
Newton	NULL
RC	NULL
.	NULL

Comparison	NULL
of	NULL
biological	NULL
17	NULL
.	NULL

De	NULL
Fougerolles	NULL
AR	NULL
,	NULL
Springer	NULL
TA	NULL
.	NULL

Intercellular	NULL
ad-	NULL
__	NULL
27	NULL
.	NULL

Myones	NULL
BL	NULL
,	NULL
Daizell	NULL
JG	NULL
,	NULL
Hogg	NULL
N	NULL
,	NULL
Ross	NULL
GD	NULL
.	NULL

Neu-	NULL
responses	NULL
of	NULL
human	NULL
monocytes	NULL
and	NULL
THP-1	NULL
cells	NULL
to	NULL
chemokines	NULL
of	NULL
the	NULL
intercrine-B	NULL
family	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
.	NULL

1994	NULL
;	NULL
55:756-762.	NULL
hesion	NULL
molecule	NULL
3	NULL
,	NULL
a	NULL
third	NULL
adhesion	NULL
counter-receptor	NULL
for	NULL
lymphocyte	NULL
function-associated	NULL
molecule	NULL
1	NULL
on	NULL
resting	NULL
lymphocytes	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1992	NULL
;	NULL
175:185-190	NULL
.	NULL

286.	NULL
trophil	NULL
and	NULL
monocyte	NULL
cell	NULL
surface	NULL
p150,95	NULL
has	NULL
iC3b-receptor	NULL
(	NULL
CR4	NULL
)	NULL
activity	NULL
resembling	NULL
CR3	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1988	NULL
;	NULL
82:640-651	NULL
.	NULL

Loike	NULL
JD	NULL
,	NULL
Sodeik	NULL
B	NULL
,	NULL
Cao	NULL
L	NULL
,	NULL
et	NULL
al	NULL
.	NULL

CD11¢c/CD18	NULL
on	NULL
5	NULL
.	NULL

Cross	NULL
AK	NULL
,	NULL
Richardson	NULL
V	NULL
,	NULL
Ali	NULL
SA	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Migration	NULL
'	NULL
.	NULL

.	NULL

.	NULL

responses	NULL
of	NULL
human	NULL
monocytic	NULL
cell	NULL
lines	NULL
to	NULL
a-	NULL
18	NULL
.	NULL

Altieri	NULL
DC	NULL
,	NULL
Edgington	NULL
TS	NULL
.	NULL

The	NULL
saturable	NULL
high	NULL
af-	NULL
neutrophils	NULL
recognizes	NULL
a	NULL
domain	NULL
at	NULL
the	NULL
N	NULL
termi-and	NULL
B-chemokines	NULL
.	NULL

Cytokine	NULL
.	NULL

1997	NULL
;	NULL
:9:521-528.	NULL
finity	NULL
association	NULL
of	NULL
factor	NULL
X	NULL
to	NULL
ADP	NULL
-stimulated	NULL
nus	NULL
of	NULL
the	NULL
A	NULL
«	NULL
chain	NULL
of	NULL
fibrinogen	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
6	NULL
.	NULL

Hynes	NULL
RO	NULL
.	NULL

Integrins	NULL
:	NULL
versatility	NULL
,	NULL
modulation	NULL
,	NULL
and	NULL
monocytes	NULL
defines	NULL
a	NULL
novel	NULL
function	NULL
of	NULL
the	NULL
Mac-1	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1991	NULL
;	NULL
88:1044-1048	NULL
.	NULL

*	NULL
signaling	NULL
in	NULL
ceuga	NULL
dhesion	NULL
Celly'1992'69'11—IZ5	NULL
receptor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1988	NULL
;	NULL
263:7007-7015	NULL
.	NULL

29	NULL
.	NULL

Ingalls	NULL
RR	NULL
,	NULL
Golenbock	NULL
DT	NULL
.	NULL

CD11¢/CD18	NULL
,	NULL
a	NULL
trans-	NULL
7	NULL
.	NULL

Larson	NULL
RS	NULL
,	NULL
Springer	NULL
TA	NULL
IStruciure	NULL
ar	NULL
;	NULL
d	NULL
fILJnctioh	NULL
of	NULL
19	NULL
.	NULL

Wright	NULL
SD	NULL
,	NULL
Levin	NULL
SM	NULL
,	NULL
Jong	NULL
MT	NULL
,	NULL
Chad	NULL
Z	NULL
,	NULL
Kabbash	NULL
membrane	NULL
signaling	NULL
3	NULL
(	NULL
oot	NULL
'	NULL
leukocyte	NULL
ilntegrins	NULL
Imrr	NULL
;	NULL
unol	NULL
Rev	NULL
.	NULL

1990	NULL
;	NULL
114:181-	NULL
LG	NULL
.	NULL

CRS	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
expresses	NULL
one	NULL
binding	NULL
ride	NULL
.	NULL

-	NULL
Exp	NULL
Med	NULL
,	NULL
1995	NULL
;	NULL
181:14783-1478	NULL
.	NULL

``	NULL
``	NULL
to	NULL
C	NULL
site	NULL
for	NULL
Arg-Gly-Asp-containing	NULL
peptides	NULL
and	NULL
a	NULL
30	NULL
.	NULL

Garnotel	NULL
R	NULL
,	NULL
Rittié	NULL
L	NULL
,	NULL
Poitevin	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Human	NULL
217	NULL
.	NULL

Arnaout	NULL
MA	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
leukocyte	NULL
adhesion	NULL
molecules	NULL
CD11/CD18	NULL
.	NULL

Blood	NULL
.	NULL

second	NULL
site	NULL
for	NULL
bacterial	NULL
lipopolysaccharide	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1989	NULL
;	NULL
169:175-183.	NULL
blood	NULL
monocytes	NULL
interact	NULL
with	NULL
type	NULL
I	NULL
collagen	NULL
through	NULL
«	NULL
yf	NULL
»	NULL
integrin	NULL
(	NULL
CD11c-CD18	NULL
,	NULL
gp150,95	NULL
)	NULL
.	NULL

1990-75:1037-1050	NULL
20	NULL
.	NULL

Altieri	NULL
DC	NULL
,	NULL
Agbanyo	NULL
FR	NULL
,	NULL
Plescia	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
unique	NULL
J	NULL
Immunol	NULL
.	NULL

2000	NULL
;	NULL
164:5928-5934.	NULL
hal	NULL
``	NULL
recognition	NULL
site	NULL
mediates	NULL
the	NULL
interaction	NULL
of	NULL
fi-	NULL
31	NULL
.	NULL

Letellier	NULL
M	NULL
,	NULL
Sarfati	NULL
M	NULL
,	NULL
Delespesse	NULL
G.	NULL
Mecha-	NULL
9	NULL
.	NULL

Van	NULL
der	NULL
Vieren	NULL
M	NULL
,	NULL
Le	NULL
Trong	NULL
H	NULL
,	NULL
Wood	NULL
CL	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
brinogen	NULL
with	NULL
the	NULL
leukocyte	NULL
integrin	NULL
Mac-1	NULL
nisms	NULL
of	NULL
formation	NULL
of	NULL
IgE-BFs	NULL
(	NULL
soluble	NULL
CD23	NULL
)	NULL
.	NULL

I.	NULL
novel	NULL
leukointegrin	NULL
,	NULL
«	NULL
dB2	NULL
,	NULL
binds	NULL
preferentially	NULL
to	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1990	NULL
;	NULL
265:12119-	NULL
FeeRII	NULL
bearing	NULL
B	NULL
cells	NULL
generate	NULL
IgE-binding	NULL
fac-ICAM-3	NULL
.	NULL

Immunity	NULL
.	NULL

1995	NULL
;	NULL
3:683-690	NULL
.	NULL

12122.	NULL
tors	NULL
of	NULL
different	NULL
molecular	NULL
weights	NULL
.	NULL

Mol	NULL
Immunol	NULL
.	NULL

10	NULL
.	NULL

Jiang	NULL
Y	NULL
,	NULL
Beller	NULL
DI	NULL
,	NULL
Frend	NULL
!	NULL

G	NULL
,	NULL
Graves	NULL
DT	NULL
.	NULL

Mono-	NULL
21	NULL
.	NULL

Diamond	NULL
MS	NULL
,	NULL
Staunton	NULL
DE	NULL
,	NULL
Marlin	NULL
SD	NULL
,	NULL
Springer	NULL
1989	NULL
;	NULL
26:1105-1112.	NULL
cyte	NULL
chemoattractant	NULL
protein-1	NULL
regulates	NULL
adhe-	NULL
TA	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
integrin	NULL
Mac-1	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
32	NULL
.	NULL

Aubry	NULL
J-P	NULL
,	NULL
Pochon	NULL
S	NULL
,	NULL
Graber	NULL
P	NULL
,	NULL
Jansen	NULL
KU	NULL
,	NULL
Bon-sion	NULL
molecule	NULL
expression	NULL
and	NULL
cytokine	NULL
produc-	NULL
to	NULL
the	NULL
third	NULL
immunoglobulin-like	NULL
domain	NULL
of	NULL
nefoy	NULL
J-Y	NULL
.	NULL

CD21	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
CD23	NULL
and	NULL
regu-tion	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1992	NULL
;	NULL
148	NULL
:	NULL
ICAM-1	NULL
(	NULL
CD54	NULL
)	NULL
and	NULL
its	NULL
regulation	NULL
by	NULL
glycosyla-	NULL
lated	NULL
IgE	NULL
production	NULL
.	NULL

Nature	NULL
.	NULL

1992	NULL
;	NULL
358:505-507	NULL
.	NULL

2423-2428.	NULL
tion	NULL
.	NULL

Cell	NULL
,	NULL
1991	NULL
;	NULL
65:961-971	NULL
.	NULL

33	NULL
.	NULL

Bonnefoy	NULL
JY	NULL
,	NULL
Aubry	NULL
JP	NULL
,	NULL
Gauchat	NULL
JF	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Recep-11	NULL
.	NULL

Vaddi	NULL
K	NULL
,	NULL
Newton	NULL
RC	NULL
.	NULL

Regulation	NULL
of	NULL
monocyte	NULL
22	NULL
.	NULL

Bilsland	NULL
CA	NULL
,	NULL
Diamond	NULL
MS	NULL
,	NULL
Springer	NULL
TA	NULL
.	NULL

The	NULL
leu-	NULL
tors	NULL
for	NULL
IgE	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
.	NULL

1993	NULL
;	NULL
5:944-947.	NULL
integrin	NULL
expression	NULL
by	NULL
B-family	NULL
chemokines	NULL
.	NULL

J	NULL
Im-	NULL
kocyte	NULL
integrin	NULL
p150,95	NULL
(	NULL
CD11c/CD18	NULL
)	NULL
as	NULL
a	NULL
re-	NULL
34	NULL
.	NULL

Lecoanet-Henchoz	NULL
S	NULL
,	NULL
Gauchat	NULL
J-F	NULL
,	NULL
Aubry	NULL
J-P	NULL
,	NULL
et	NULL
munol	NULL
.	NULL

1994	NULL
;	NULL
153:4721-4732.	NULL
ceptor	NULL
for	NULL
iC3b	NULL
:	NULL
activation	NULL
by	NULL
a	NULL
heterologous	NULL
B	NULL
al	NULL
.	NULL

CD23	NULL
regulates	NULL
monocyte	NULL
activation	NULL
through	NULL
a	NULL
12	NULL
.	NULL

Conklyn	NULL
MJ	NULL
,	NULL
Neote	NULL
K	NULL
,	NULL
Showell	NULL
HJ	NULL
.	NULL

Chemokine-	NULL
subunit	NULL
and	NULL
localization	NULL
of	NULL
a	NULL
ligand	NULL
recognition	NULL
novel	NULL
interaction	NULL
with	NULL
the	NULL
adhesion	NULL
molecules	NULL
dependent	NULL
up-regulation	NULL
of	NULL
CD11b	NULL
on	NULL
specific	NULL
site	NULL
to	NULL
the	NULL
|	NULL
domain	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1994	NULL
;	NULL
152:4582-	NULL
CD11b-CD18	NULL
and	NULL
CD11c-CD18	NULL
.	NULL

Immunity	NULL
.	NULL

1995	NULL
;	NULL
leukocyte	NULL
subpopulations	NULL
in	NULL
human	NULL
whole	NULL
blood	NULL
:	NULL
4589	NULL
.	NULL

3:119-125.	NULL
effect	NULL
of	NULL
anticoagulant	NULL
on	NULL
RANTES	NULL
and	NULL
MIP-1	NULL
B	NULL
23	NULL
.	NULL

Coombe	NULL
DR	NULL
,	NULL
Watt	NULL
SM	NULL
,	NULL
Parish	NULL
CR	NULL
.	NULL

(	NULL
CD11b/	NULL
35	NULL
.	NULL

Bonnefoy	NULL
J-Y	NULL
,	NULL
Plater-Zyberk	NULL
C	NULL
,	NULL
Lecoanet-Hen-stimulation	NULL
.	NULL

Cytokine	NULL
.	NULL

1996	NULL
;	NULL
8:762-766	NULL
.	NULL

CD18	NULL
)	NULL
and	NULL
CD45	NULL
mediate	NULL
the	NULL
adhesion	NULL
of	NULL
hema-	NULL
choz	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
new	NULL
role	NULL
for	NULL
CD23	NULL
in	NULL
inflamma-13	NULL
.	NULL

Landis	NULL
RC	NULL
,	NULL
McDowall	NULL
A	NULL
,	NULL
Holness	NULL
HLL	NULL
,	NULL
et	NULL
al	NULL
.	NULL

In-	NULL
topoietic	NULL
progenitor	NULL
cells	NULL
to	NULL
stroma	NULL
cell	NULL
elements	NULL
tion	NULL
.	NULL

Immunol	NULL
Today	NULL
.	NULL

1996	NULL
;	NULL
17:418-420.	NULL
volvement	NULL
of	NULL
the	NULL
``	NULL
I	NULL
``	NULL
domain	NULL
of	NULL
LFA-1	NULL
in	NULL
selective	NULL
via	NULL
recognition	NULL
of	NULL
stromal	NULL
heparin	NULL
sulfate	NULL
.	NULL

Blood	NULL
.	NULL

36	NULL
.	NULL

Lecoanet-Henchoz	NULL
S	NULL
,	NULL
Plater-Zyberk	NULL
C	NULL
,	NULL
Graber	NULL
P	NULL
,	NULL
binding	NULL
to	NULL
ligands	NULL
ICAM-1	NULL
and	NULL
ICAM-3	NULL
.	NULL

J	NULL
Cell	NULL
1994	NULL
;	NULL
84:739-752.	NULL
et	NULL
al	NULL
.	NULL

Mouse	NULL
CD23	NULL
regulates	NULL
monocyte	NULL
activation	NULL
Biol	NULL
.	NULL

1994	NULL
;	NULL
126:529-537	NULL
.	NULL

24	NULL
.	NULL

Walzog	NULL
B	NULL
,	NULL
Schuppan	NULL
D	NULL
,	NULL
Heimpel	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
through	NULL
an	NULL
interaction	NULL
with	NULL
the	NULL
adhesion	NULL
molecule	NULL
14	NULL
.	NULL

Staunton	NULL
DE	NULL
,	NULL
Dustin	NULL
ML	NULL
,	NULL
Springer	NULL
TA	NULL
.	NULL

Functional	NULL
leukocyte	NULL
integrin	NULL
Mac-1	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
contrib-	NULL
CD11b/CD18	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
.	NULL

1997	NULL
;	NULL
27:2290-cloning	NULL
of	NULL
ICAM-2	NULL
,	NULL
a	NULL
cell	NULL
adhesion	NULL
ligand	NULL
for	NULL
utes	NULL
to	NULL
binding	NULL
of	NULL
human	NULL
granulocytes	NULL
to	NULL
colla-	NULL
2294	NULL
.	NULL

LFA-1	NULL
homologous	NULL
to	NULL
ICAM-1	NULL
.	NULL

Nature	NULL
.	NULL

1989	NULL
;	NULL
339	NULL
:	NULL
gen.	NULL
Exp	NULL
Cell	NULL
Res	NULL
.	NULL

1995	NULL
;	NULL
218:28-38	NULL
.	NULL

37	NULL
.	NULL

Aubry	NULL
J-P	NULL
,	NULL
Dugas	NULL
N	NULL
,	NULL
Lecoanet-Henchoz	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

61-64	NULL
.	NULL

25	NULL
.	NULL

Diamond	NULL
MS	NULL
,	NULL
Alon	NULL
R	NULL
,	NULL
Parkos	NULL
CA	NULL
,	NULL
Quinn	NULL
MT	NULL
,	NULL
The	NULL
25-kDa	NULL
soluble	NULL
CD23	NULL
activates	NULL
type	NULL
III	NULL
con-15	NULL
.	NULL

De	NULL
Fougerolles	NULL
AR	NULL
,	NULL
Stacker	NULL
SA	NULL
,	NULL
Schwarting	NULL
R	NULL
,	NULL
Springer	NULL
TA	NULL
.	NULL

Heparin	NULL
is	NULL
an	NULL
adhesive	NULL
ligand	NULL
for	NULL
the	NULL
stitutive	NULL
nitric	NULL
oxide-synthase	NULL
activity	NULL
via	NULL
CD11b	NULL
2940	NULL
38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REZZONICO	NULL
et	NULL
al	NULL
and	NULL
CD11¢c	NULL
expressed	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1997	NULL
;	NULL
159:614-622	NULL
.	NULL

Fan	NULL
ST	NULL
,	NULL
Edgington	NULL
TS	NULL
.	NULL

Integrin	NULL
regulation	NULL
of	NULL
leukocyte	NULL
inflammatory	NULL
functions	NULL
:	NULL
CD11b/CD18	NULL
enhancement	NULL
of	NULL
the	NULL
turnor	NULL
necrosis	NULL
factor-	NULL
«	NULL
responses	NULL
of	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1993	NULL
;	NULL
150	NULL
:	NULL
2972-2980	NULL
.	NULL

Dackiw	NULL
APB	NULL
,	NULL
Nathens	NULL
AB	NULL
,	NULL
Marshall	NULL
JC	NULL
,	NULL
Rotstein	NULL
OD	NULL
.	NULL

Integrin	NULL
engagement	NULL
induces	NULL
monocyte	NULL
procoagulant	NULL
activity	NULL
and	NULL
tunor	NULL
necrosis	NULL
factor	NULL
pro	NULL
duction	NULL
via	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

J	NULL
Surg	NULL
Res	NULL
.	NULL

1996	NULL
;	NULL
64:210-215	NULL
.	NULL

Yamada	NULL
A	NULL
,	NULL
Hara	NULL
A	NULL
,	NULL
Inoue	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

B2-integrin-mediated	NULL
signal	NULL
up-regulates	NULL
counter-receptor	NULL
ICAM-1	NULL
expression	NULL
on	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
through	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
Immunol	NULL
.	NULL

1997	NULL
;	NULL
178:9-16	NULL
.	NULL

Rezzonico	NULL
R	NULL
,	NULL
Chicheportiche	NULL
R	NULL
,	NULL
Imbert	NULL
V	NULL
,	NULL
Dayer	NULL
JM	NULL
.	NULL

Engagement	NULL
of	NULL
CD11b	NULL
and	NULL
CD11¢c	NULL
B	NULL
;	NULL
integrin	NULL
by	NULL
antibodies	NULL
or	NULL
soluble	NULL
CD23	NULL
induces	NULL
IL-16	NULL
production	NULL
on	NULL
primary	NULL
human	NULL
monocytes	NULL
through	NULL
mitogen-activated	NULL
protein	NULL
kinase-dependent	NULL
pathways	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:3868-3877	NULL
.	NULL

Lukacs	NULL
NW	NULL
,	NULL
Strieter	NULL
RM	NULL
,	NULL
Elner	NULL
V	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Intercellular	NULL
adhesion	NULL
molecule-1	NULL
mediates	NULL
the	NULL
expression	NULL
of	NULL
monocyte-derived	NULL
MIP-1	NULL
a	NULL
during	NULL
monocyte-endothelial	NULL
cell	NULL
interactions	NULL
.	NULL

Blood	NULL
.	NULL

1994	NULL
;	NULL
83	NULL
:	NULL
1174-1178	NULL
.	NULL

Lukacs	NULL
NW	NULL
,	NULL
Strieter	NULL
RM	NULL
,	NULL
Elner	NULL
V	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Production	NULL
of	NULL
chemokines	NULL
,	NULL
interleukin-8	NULL
and	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
,	NULL
during	NULL
monocyte	NULL
:	NULL
en-dothelial	NULL
cell	NULL
interactions	NULL
.	NULL

Blood	NULL
.	NULL

1995	NULL
;	NULL
86:2767-2773	NULL
.	NULL

Allet	NULL
B	NULL
,	NULL
Bernard	NULL
AR	NULL
,	NULL
Hochmann	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
bacterial	NULL
signal	NULL
peptide	NULL
directs	NULL
efficient	NULL
secretion	NULL
of	NULL
eukaryotic	NULL
proteins	NULL
in	NULL
the	NULL
baculovirus	NULL
expression	NULL
system	NULL
.	NULL

Protein	NULL
Expr	NULL
Purif	NULL
.	NULL

1997	NULL
;	NULL
9:61-68	NULL
.	NULL

Mentzer	NULL
SJ	NULL
,	NULL
Guyre	NULL
PM	NULL
,	NULL
Burakoff	NULL
SJ	NULL
,	NULL
Faller	NULL
DV	NULL
.	NULL

Spontaneous	NULL
aggregation	NULL
as	NULL
a	NULL
mechanism	NULL
for	NULL
human	NULL
monocyte	NULL
purification	NULL
.	NULL

Cell	NULL
Immunol	NULL
.	NULL

1986	NULL
;	NULL
101:312-319	NULL
.	NULL

Duff	NULL
GW	NULL
,	NULL
Atkins	NULL
E.	NULL
The	NULL
inhibitory	NULL
effect	NULL
of	NULL
polymyxin	NULL
B	NULL
on	NULL
endotoxin-induced	NULL
endogenous	NULL
pyro-gen	NULL
production	NULL
.	NULL

J	NULL
Immunol	NULL
Methods	NULL
.	NULL

1982	NULL
;	NULL
52	NULL
:	NULL
333-340	NULL
.	NULL

Schreiber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Miiller	NULL
MM	NULL
,	NULL
Schaffner	NULL
W.	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

1989	NULL
;	NULL
17:6419	NULL
.	NULL

Armant	NULL
M	NULL
,	NULL
Rubio	NULL
M	NULL
,	NULL
Delespesse	NULL
G	NULL
,	NULL
Sarfati	NULL
M.	NULL
Soluble	NULL
CD23	NULL
directly	NULL
activates	NULL
monocytes	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
antigen-independent	NULL
stimulation	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1995	NULL
;	NULL
155:4868-4875	NULL
.	NULL

Taub	NULL
DD	NULL
,	NULL
Oppenheim	NULL
JJ	NULL
.	NULL

Chemokines	NULL
,	NULL
inflammation	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Ther	NULL
Immunol	NULL
.	NULL

1994	NULL
;	NULL
1:229-246	NULL
.	NULL

Juliano	NULL
RL	NULL
,	NULL
Haskill	NULL
S.	NULL
Signal	NULL
transduction	NULL
from	NULL
the	NULL
extracellular	NULL
matrix	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
.	NULL

1993	NULL
;	NULL
120	NULL
:	NULL
577-585	NULL
.	NULL

Smith	NULL
RE	NULL
,	NULL
Strieter	NULL
RM	NULL
,	NULL
Phan	NULL
SH	NULL
,	NULL
Lukacs	NULL
N	NULL
,	NULL
Kunkel	NULL
SL	NULL
.	NULL

TNF	NULL
and	NULL
IL-6	NULL
mediate	NULL
MIP-1a	NULL
expression	NULL
in	NULL
bleomycin-induced	NULL
lung	NULL
injury	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
64:528-536	NULL
.	NULL

Taichman	NULL
RS	NULL
,	NULL
Reilly	NULL
MJ	NULL
,	NULL
Matthews	NULL
LS	NULL
.	NULL

Human	NULL
osteoblast-like	NULL
cells	NULL
and	NULL
osteosarcoma	NULL
cell	NULL
lines	NULL
synthesize	NULL
macrophage	NULL
inhibitory	NULL
protein	NULL
1	NULL
«	NULL
in	NULL
response	NULL
to	NULL
interleukin	NULL
16	NULL
and	NULL
tumour	NULL
necrosis	NULL
factor	NULL
«	NULL
stimulation	NULL
in	NULL
vitro	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
.	NULL

2000	NULL
;	NULL
108:275-283	NULL
.	NULL

Grove	NULL
M	NULL
,	NULL
Plumb	NULL
M.	NULL
C/EBP	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Ets	NULL
family	NULL
members	NULL
and	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
cell-specific	NULL
and	NULL
inducible	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
«	NULL
immediate-early	NULL
gene	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1993	NULL
;	NULL
13:5276-5289	NULL
.	NULL

Henkel	NULL
T	NULL
,	NULL
Machleidt	NULL
T	NULL
,	NULL
Alkalay	NULL
1	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IkB-a	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67.	NULL
a	NULL
69	NULL
.	NULL

70.	NULL
transcription	NULL
factor	NULL
NFB	NULL
.	NULL

Nature	NULL
.	NULL

1993	NULL
;	NULL
365:182-185	NULL
.	NULL

Palombella	NULL
VJ	NULL
,	NULL
Rando	NULL
OJ	NULL
,	NULL
Goldberg	NULL
AL	NULL
,	NULL
Maniatis	NULL
T.	NULL
The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NFkB1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NFB	NULL
.	NULL

Cell	NULL
.	NULL

1994	NULL
;	NULL
78:773-785	NULL
.	NULL

Alkalay	NULL
I	NULL
,	NULL
Yaron	NULL
A	NULL
,	NULL
Hatzubai	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Stimulation-dependent	NULL
IkB-	NULL
«	NULL
phosphorylation	NULL
marks	NULL
the	NULL
NF-B	NULL
inhibitor	NULL
for	NULL
degradation	NULL
via	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1995	NULL
;	NULL
92:10599-10603	NULL
.	NULL

Baldwin	NULL
AS	NULL
.	NULL

The	NULL
NFB	NULL
and	NULL
IkB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
.	NULL

1996	NULL
;	NULL
14:649-681	NULL
.	NULL

Sun	NULL
S-C	NULL
,	NULL
Ganchi	NULL
PA	NULL
,	NULL
Ballard	NULL
DW	NULL
,	NULL
Greene	NULL
WC	NULL
.	NULL

NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IkB-a	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
.	NULL

1993	NULL
;	NULL
259:1912-1915	NULL
.	NULL

Traenckner	NULL
EB-M	NULL
,	NULL
Wilk	NULL
S	NULL
,	NULL
Bauerle	NULL
PA.	NULL
A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IkB-a	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1994	NULL
;	NULL
13	NULL
:	NULL
5433-5441	NULL
.	NULL

Schow	NULL
SR	NULL
,	NULL
Joly	NULL
A.	NULL
N-Acetyl-leucinyl-leucinyl-nor-leucinal	NULL
inhibits	NULL
lipopolysaccharide-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
prevents	NULL
TNF	NULL
and	NULL
IL-6	NULL
synthesis	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
Immunol	NULL
.	NULL

1997	NULL
;	NULL
175:199-202	NULL
.	NULL

Imbert	NULL
V	NULL
,	NULL
Rupec	NULL
RA	NULL
,	NULL
Livolsi	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
IkB-	NULL
«	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
without	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IkB-a	NULL
.	NULL

Cell	NULL
.	NULL

1996	NULL
;	NULL
86	NULL
:	NULL
787-798	NULL
.	NULL

Detmers	NULL
PA	NULL
,	NULL
Lo	NULL
SK	NULL
,	NULL
Olsen-Egbert	NULL
E	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Neu-trophil-activating	NULL
protein	NULL
1/1L-8	NULL
stimulates	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
leukocyte	NULL
adhesion	NULL
receptor	NULL
CD11b/CD18	NULL
on	NULL
human	NULL
neutrophils	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1990	NULL
;	NULL
171:1155-1162	NULL
.	NULL

Weber	NULL
KSC	NULL
,	NULL
Klickstein	NULL
LB	NULL
,	NULL
Weber	NULL
C.	NULL
Specific	NULL
activation	NULL
of	NULL
leukocyte	NULL
B	NULL
;	NULL
integrins	NULL
lymphocyte	NULL
function-associated	NULL
antigen-1	NULL
and	NULL
Mac-1	NULL
by	NULL
chemokines	NULL
mediated	NULL
by	NULL
distinct	NULL
pathways	NULL
via	NULL
the	NULL
«	NULL
subunit	NULL
cytoplasmic	NULL
domains	NULL
.	NULL

Mol	NULL
Biol	NULL
Cell	NULL
.	NULL

1999	NULL
;	NULL
10:861-873	NULL
.	NULL

Lukacs	NULL
NW	NULL
,	NULL
Chensue	NULL
SW	NULL
,	NULL
Smith	NULL
RE	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Production	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
and	NULL
macrophage	NULL
inflammatory	NULL
protein-1	NULL
«	NULL
by	NULL
inflammatory	NULL
granuloma	NULL
fibroblasts	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
.	NULL

1994	NULL
;	NULL
144:711-718	NULL
.	NULL

Weyrich	NULL
AS	NULL
,	NULL
Elstad	NULL
MR	NULL
,	NULL
McEver	NULL
RP	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Activated	NULL
platelets	NULL
signal	NULL
chemokine	NULL
synthesis	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1996	NULL
;	NULL
97:1525-1534	NULL
.	NULL

Zickus	NULL
C	NULL
,	NULL
Kunkel	NULL
SL	NULL
,	NULL
Simpson	NULL
K	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
C-C	NULL
chemokines	NULL
during	NULL
fibro-blast-monocyte	NULL
interactions	NULL
:	NULL
adhesion	NULL
vs	NULL
inflammatory	NULL
cytokine	NULL
pathways	NULL
.	NULL

Mediators	NULL
Inflamm	NULL
.	NULL

1998	NULL
;	NULL
7:269-274	NULL
.	NULL

Steinhauser	NULL
ML	NULL
,	NULL
Kunkel	NULL
SL	NULL
,	NULL
Hogaboarn	NULL
CM	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Macrophage/fibroblast	NULL
coculture	NULL
induces	NULL
macrophage	NULL
inflammatory	NULL
protein-1	NULL
«	NULL
production	NULL
mediated	NULL
by	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
oxygen	NULL
radicals	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
64:636-641	NULL
.	NULL

Walzog	NULL
B	NULL
,	NULL
Weinmann	NULL
P	NULL
,	NULL
Jeblonski	NULL
F	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
role	NULL
for	NULL
Bs	NULL
integrins	NULL
(	NULL
CD11/CD18	NULL
)	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
of	NULL
polymorphonuclear	NULL
neutrophils	NULL
during	NULL
the	NULL
inflammatory	NULL
response	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

1999	NULL
;	NULL
13:1855-1865	NULL
.	NULL

VanOiteren	NULL
GM	NULL
,	NULL
Standiford	NULL
TJ	NULL
,	NULL
Kunkel	NULL
SL	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Expression	NULL
and	NULL
regulation	NULL
of	NULL
macrophage	NULL
inflammatory	NULL
protein-1	NULL
a	NULL
by	NULL
murine	NULL
alveolar	NULL
and	NULL
perito-neal	NULL
macrophages	NULL
.	NULL

Am	NULL
J	NULL
Respir	NULL
Cell	NULL
Mol	NULL
Biol	NULL
.	NULL

1994	NULL
;	NULL
10:8-15	NULL
.	NULL

Vey	NULL
E	NULL
,	NULL
Zhang	NULL
JH	NULL
,	NULL
Dayer	NULL
JM	NULL
.	NULL

IFN-y	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D3	NULL
induce	NULL
on	NULL
THP-1	NULL
cells	NULL
distinct	NULL
patterns	NULL
of	NULL
cell	NULL
surface	NULL
antigen	NULL
expression	NULL
,	NULL
cytokine	NULL
production	NULL
and	NULL
responsiveness	NULL
to	NULL
contact	NULL
with	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1992	NULL
;	NULL
149:2040-2046	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
10	NULL
71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

Isler	NULL
P	NULL
,	NULL
Vey	NULL
E	NULL
,	NULL
Zhang	NULL
JH	NULL
,	NULL
Dayer	NULL
JM	NULL
.	NULL

Cell	NULL
surface	NULL
glycoproteins	NULL
expressed	NULL
on	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
induce	NULL
production	NULL
of	NULL
interleukin-1	NULL
B	NULL
by	NULL
monocytic	NULL
cells	NULL
:	NULL
a	NULL
possible	NULL
role	NULL
of	NULL
CD69	NULL
.	NULL

Eur	NULL
Cytokine	NULL
Netw	NULL
.	NULL

1993	NULL
;	NULL
4:15-23	NULL
.	NULL

Armant	NULL
M	NULL
,	NULL
Ishihara	NULL
H	NULL
,	NULL
Rubio	NULL
M	NULL
,	NULL
Delespesse	NULL
G	NULL
,	NULL
Sarfati	NULL
M.	NULL
Regulation	NULL
of	NULL
cytokine	NULL
production	NULL
by	NULL
soluble	NULL
CD23	NULL
:	NULL
costimulation	NULL
of	NULL
interferon	NULL
y	NULL
secretion	NULL
and	NULL
triggering	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
re-lease	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1994	NULL
;	NULL
180:1005-1011	NULL
.	NULL

Kunsch	NULL
C	NULL
,	NULL
Rosen	NULL
CA	NULL
.	NULL

NF-kB	NULL
subunit-specific	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-8	NULL
promoter	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1993	NULL
;	NULL
13:6137-6146	NULL
.	NULL

Sitrin	NULL
RG	NULL
,	NULL
Pan	NULL
PM	NULL
,	NULL
Srikanth	NULL
S	NULL
,	NULL
Todd	NULL
RF	NULL
III	NULL
.	NULL

Fibrinogen	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1998	NULL
;	NULL
161	NULL
:	NULL
1462-1470	NULL
.	NULL

Haas	NULL
M	NULL
,	NULL
Page	NULL
S	NULL
,	NULL
Page	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Effect	NULL
of	NULL
proteasome	NULL
inhibitors	NULL
on	NULL
monocytic	NULL
IkB-a	NULL
and	NULL
-8	NULL
deple-tion	NULL
,	NULL
NF-kB	NULL
activation	NULL
,	NULL
and	NULL
cytokine	NULL
production	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
63:395-404	NULL
.	NULL

Koch	NULL
AE	NULL
,	NULL
Kunkel	NULL
SL	NULL
,	NULL
Harlow	NULL
LA	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Macrophage	NULL
inflammatory	NULL
protein-1	NULL
«	NULL
:	NULL
a	NULL
novel	NULL
chemotactic	NULL
cytokine	NULL
for	NULL
macrophages	NULL
in	NULL
rheurnatoid	NULL
arthritis	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1994	NULL
;	NULL
93:921-928	NULL
.	NULL

Koch	NULL
AE	NULL
,	NULL
Kunkel	NULL
SL	NULL
,	NULL
Shah	NULL
MR	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Macrophage	NULL
inflammatory	NULL
protein-1	NULL
B	NULL
:	NULL
a	NULL
C-C	NULL
chemokine	NULL
in	NULL
osteoarthritis	NULL
.	NULL

Clin	NULL
Immunol	NULL
Immuno-pathol	NULL
.	NULL

1995	NULL
;	NULL
77:307-314	NULL
.	NULL

Fuller	NULL
K	NULL
,	NULL
Owens	NULL
JM	NULL
,	NULL
Chambers	NULL
TJ	NULL
.	NULL

Macrophage	NULL
inflammatory	NULL
protein-1	NULL
a	NULL
and	NULL
IL-8	NULL
stimulate	NULL
the	NULL
motility	NULL
but	NULL
suppress	NULL
the	NULL
resorption	NULL
of	NULL
isolated	NULL
rat	NULL
osteoclasts	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1995	NULL
;	NULL
154:6065-6072	NULL
.	NULL

Chomarat	NULL
P	NULL
,	NULL
Briolay	NULL
J	NULL
,	NULL
Banchereau	NULL
J	NULL
,	NULL
Miossec	NULL
P.	NULL
Increased	NULL
production	NULL
of	NULL
soluble	NULL
CD23	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
and	NULL
its	NULL
regulation	NULL
by	NULL
interleukin-4	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

1993	NULL
;	NULL
36:234-242	NULL
.	NULL

Huissoon	NULL
AP	NULL
,	NULL
Emery	NULL
P	NULL
,	NULL
Bacon	NULL
PA	NULL
,	NULL
Gordon	NULL
J	NULL
,	NULL
Salmon	NULL
M.	NULL
Increased	NULL
expression	NULL
of	NULL
CD23	NULL
in	NULL
rheumatoid	NULL
synovitis	NULL
.	NULL

Scand	NULL
J	NULL
Rheumatol	NULL
.	NULL

2000	NULL
;	NULL
29:154-159	NULL
.	NULL

Ribbens	NULL
C	NULL
,	NULL
Bonnet	NULL
V	NULL
,	NULL
Kaiser	NULL
MJ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Increased	NULL
synovial	NULL
fluid	NULL
levels	NULL
of	NULL
soluble	NULL
CD23	NULL
are	NULL
associated	NULL
with	NULL
an	NULL
erosive	NULL
status	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
RA	NULL
)	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
.	NULL

2000	NULL
;	NULL
120:194-199	NULL
.	NULL

Torsteinsdottir	NULL
I	NULL
,	NULL
Arvidson	NULL
NG	NULL
,	NULL
Hallgren	NULL
R	NULL
,	NULL
Ha-kansson	NULL
L.	NULL
Monocyte	NULL
activation	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
RA	NULL
)	NULL
:	NULL
increased	NULL
integrin	NULL
,	NULL
Ec	NULL
gamma	NULL
and	NULL
complement	NULL
receptor	NULL
expression	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
glucocorticoids	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
.	NULL

1999	NULL
;	NULL
115:554-560	NULL
.	NULL

Baggiolini	NULL
M	NULL
,	NULL
Moser	NULL
B	NULL
.	NULL

Blocking	NULL
chemokine	NULL
re-ceptors	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1997	NULL
;	NULL
186:1189-1191	NULL
.	NULL

Cornejo	NULL
CJ	NULL
,	NULL
Winn	NULL
RK	NULL
,	NULL
Harlan	NULL
JM	NULL
.	NULL

Anti-adhesion	NULL
therapy	NULL
.	NULL

Adv	NULL
Pharmacol	NULL
.	NULL

1997	NULL
;	NULL
39:99-142	NULL
.	NULL

Diaz-Gonzalez	NULL
F	NULL
,	NULL
Sanchez-Madrid	NULL
F.	NULL
Inhibition	NULL
of	NULL
leukocyte	NULL
adhesion	NULL
:	NULL
an	NULL
alternative	NULL
mechanism	NULL
of	NULL
action	NULL
for	NULL
anti-inflammatory	NULL
drugs	NULL
.	NULL

Immunol	NULL
Today	NULL
.	NULL

1998	NULL
;	NULL
19:169-172	NULL
.	NULL

Foxwell	NULL
BMJ	NULL
,	NULL
Browne	NULL
KA	NULL
,	NULL
Bondeson	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Efficient	NULL
adenoviral	NULL
infection	NULL
with	NULL
IkB	NULL
«	NULL
reveals	NULL
that	NULL
macrophage	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
production	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
is	NULL
NF-kB	NULL
dependent	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1998	NULL
;	NULL
95:8211-8215	NULL
.	NULL

Bondeson	NULL
J	NULL
,	NULL
Browne	NULL
KA	NULL
,	NULL
Brennan	NULL
FM	NULL
,	NULL
Foxwell	NULL
BMJ	NULL
,	NULL
Feldmann	NULL
M.	NULL
Selective	NULL
regulation	NULL
of	NULL
cytokine	NULL
induction	NULL
by	NULL
adenoviral	NULL
gene	NULL
transfer	NULL
of	NULL
IkBo	NULL
.	NULL

into	NULL
human	NULL
macrophages	NULL
:	NULL
lipopolysaccharide-induced	NULL
,	NULL
but	NULL
not	NULL
zymosan-induced	NULL
,	NULL
proinflammatory	NULL
cytokines	NULL
are	NULL
inhibited	NULL
,	NULL
but	NULL
IL-10	NULL
is	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
independent	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1999	NULL
;	NULL
162	NULL
:	NULL
2939-2945	NULL
.	NULL

Bondeson	NULL
J	NULL
,	NULL
Foxwell	NULL
BMJ	NULL
,	NULL
Brennan	NULL
FM	NULL
,	NULL
Feldmann	NULL
M.	NULL
Defining	NULL
therapeutic	NULL
targets	NULL
by	NULL
using	NULL
adenovirus	NULL
:	NULL
blocking	NULL
NF-	NULL
«	NULL
B	NULL
inhibits	NULL
both	NULL
inflammatory	NULL
and	NULL
destructive	NULL
mechanisms	NULL
in	NULL
rheumatoid	NULL
synovium	NULL
but	NULL
spares	NULL
anti-inflammatory	NULL
me-diators	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1999	NULL
;	NULL
96:5668-5673	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
2001	NULL
97	NULL
:	NULL
2932-2940	NULL
doi:10.1182/blood.V97.10.2932	NULL
Ligation	NULL
of	NULL
CD11b	NULL
and	NULL
CD11c¢	NULL
B	NULL
»	NULL
integrins	NULL
by	NULL
antibodies	NULL
or	NULL
soluble	NULL
CD23	NULL
induces	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
«	NULL
(	NULL
MIP-1	NULL
«	NULL
)	NULL
and	NULL
production	NULL
in	NULL
primary	NULL
human	NULL
monocytes	NULL
through	NULL
a	NULL
pathway	NULL
dependent	NULL
on	NULL
nuclear	NULL
factor-	NULL
«	NULL
xB	NULL
o	NULL
)	NULL
A	NULL
--	NULL
0	NULL
%	NULL
A	NULL
_	NULL
o	NULL
%	NULL
p	NULL
'	NULL
c	NULL
Eh	NULL
)	NULL
``	NULL
I	NULL
f	NULL
``	NULL
C100	NULL
\	NULL
e	NULL
Roger	NULL
Rezzonico	NULL
,	NULL
Veronique	NULL
Imbert	NULL
,	NULL
Rachel	NULL
Chicheportiche	NULL
and	NULL
Jean-Michel	NULL
Dayer	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/97/10/2932.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Chemokines	NULL
,	NULL
Cytokines	NULL
,	NULL
and	NULL
Interleukins	NULL
(	NULL
564	NULL
articles	NULL
)	NULL
Gene	NULL
Expression	NULL
(	NULL
1086	NULL
articles	NULL
)	NULL
Signal	NULL
Transduction	NULL
(	NULL
1930	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

